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ABSTRACT

Investigations of Prokaryotic Defense Systems
by
Hannah Domgaard, Master of Science
Utah State University, 2022
Major Professor: Ryan Jackson, Ph.D.
Department: Chemistry and Biochemistry
Prokaryotic defense systems utilize protein-mediated mechanisms and chemical
signaling to protect against mobile genetic elements (MGEs) such as phages and
plasmids. This thesis contains studies of two defense systems, CRISPR-Cas (Clustered
Regularly Interspaced Short Palindromic Repeats - CRISPR Associated) and Wadjet
systems. CRISPR-Cas systems defend against MGEs with programmable complexes
composed of protein and an RNA guide. The general defense mechanisms of five of the
six CRISPR system types are known. However, many CRISPR systems, such as type IV
and variant systems such as type V-A2, remain uncharacterized. Type IV systems lack
nuclease-associated genes, making it difficult to predict how immune function is
delivered. To better understand type IV function, we identified a type IV-A CRISPR
operon in Pseudomonas aeruginosa strain 83 adjacent to a damage-inducible helicase
(dinG-like) gene. This thesis describes some of the first biochemical and structural
studies performed on a CRISPR-associated DinG protein (CasDinG), showing that
CasDinG is an ATP-dependent helicase that plays a pivotal role in type IV-A function.
Type V systems house many potent genome editing tools, such as Cas9 and Cas12a.
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Bioinformatic analysis identified new variant subtypes of Cas12a called Cas12a2.
Cas12a2 was recently used to create insertion-deletion events in eukaryotic cell lines.
However, how these variant proteins generated double-strand DNA (dsDNA) breaks is
unknown. This thesis describes preliminary studies performed on Cas12a2 variants
showing that they can process and bind nucleic acids.
Wadjet systems share homology with Escherichia coli chromosome condensin
complexes, and recent research has shown that they limit the transformation efficiency of
plasmids. However, the mechanism behind this action remains unknown. This thesis
describes preliminary studies performed on Azotobacter vinelandii JetB and the cloning
of Wadjet genes. This work is essential as conducting basic research on prokaryotic
immune systems has continuously led to the development of innovative tools used in
genome editing and medical and scientific research.
(180 pages)
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PUBLIC ABSTRACT

Investigations of Prokaryotic Defense Systems
Hannah Domgaard
Bacteria are constantly threatened with infection by mobile genetic elements
(MGE) such as bacteriophage and plasmids. Bacteriophage and plasmids require the
bacteria's cellular infrastructure to replicate their genomes. Rampant replication can lead
to cell death which is one reason why bacteria have developed a diverse array of immune
systems to prevent or limit infection. This thesis studies three types of bacterial immune
systems, type IV-A CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic
Repeat – CRISPR associated), type V-A2 CRISPR-Cas systems, and Wadjet systems.
The type IV-A system lies adjacent to a dinG-like helicase gene. Research has
shown that this system can target plasmids preventing their spread throughout a microbial
population. This system is reliant upon the dinG-like gene, but how this system
mechanistically prevents plasmid sharing is not understood.
The type V-A2 system has been shown to be capable of editing the genome of
rice by generating breaks in the DNA. How this editing takes place, and the other
biochemical mechanisms of this protein are not understood either. This thesis provides
the preliminary framework for studying these putative genome editing tools.
Wadjet immune systems prevent the sharing of plasmids between bacteria. These
systems share structural similarities with proteins responsible for separating bacterial
chromosomes during cellular replication. This thesis contains the foundation for the
characterization of the system by cloning genes from native host systems and then
recombinantly expressing and purifying proteins.
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dsDNA/ssDNA Double-stranded or single-stranded deoxyribonucleic acid
dsRNA/ssRNA

double stranded or single stranded ribonucleic acid
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damage inducible gene G
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nuclease domain
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ribonucleoprotein complex
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CHAPTER 1
INTRODUCTION

Bacterial Immune Systems
Mobile genetic elements (MGE), such as bacteriophages and plasmids, rely upon
prokaryotic hosts to replicate their genetic material (del Solar et al., 1998; Rampersad &
Tennant, 2018). This reliance comes at a high cost for the microbes, often resulting in cell
death (Suttle, 2007). The evolutionary pressure resulting from prokaryotic and MGE
interactions has resulted in an arms race, with the development of microbial defense
systems on the one hand and the generation of viral counter defense pathways that
prevent microbial defense on the other (Stern & Sorek, 2010, Makarova et al., 2011;
Fortier & Sekulovic, 2013; Pawluk et al., 2017). These microbial defenses or immune
systems utilize protein machinery, nucleic acid, and chemical signaling systems to
identify and defend against invasive genetic elements (Stern & Sorek, 2010; Hall et al.,
2011; Bernheim & Sorek, 2019). For example, restriction-modification systems use
restriction enzymes that bind and cleave specific nucleic acid sequences, and abortive
infections utilize chemical signaling pathways which result in host cell death rather than
the death of the bacterial colony.
New microbial immune systems and variants within those systems are being
discovered yearly and are prime targets for new research projects. For example, toxinantitoxin systems, bacteriophage exclusion (BREX) systems, CRISPR-Cas (Clustered
Regularly Interspaced Short Palindromic Repeats – CRISPR associated) systems, Wadjet,
Thoeris, Septu, and others require further biochemical and structural characterization
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(Labrie et al., 2010; Westra et al., 2012; Goldfarb et al., 2014; Doron et al., 2018). The
study of prokaryotic immune systems is vital, as basic research identifies and promotes
the development of tools that can be repurposed for scientific and medical research and or
diagnostics. For instance, the study of CRISPR-Cas systems led to the research and
development of viral diagnostic tests used to detect the presence of SARS-CoV-2, a virus
associated with a recent pandemic (Broughton et al., 2020; Rahimi et al., 2021).
Furthermore, research on CRISPR systems is leading to the development of treatments
for HIV-1, sickle cell, cancer, and blindness (Ledford, 2020; Frangoul et al., 2021;
Herskovitz et al., 2021; Katti et al., 2022).
This thesis will focus primarily on CRISPR-Cas and Wadjet systems, described in
detail in chapters two and three. Characterization of these systems is performed using
both in vivo and in vitro biochemical assays and structural analysis using cryo-electron
microscopy and x-ray crystallography.

CRISPR-Cas Prokaryotic Adaptive Immune Systems
Bacteria and archaea utilize CRISPR-Cas systems to defend against MGE.
CRISPR-Cas systems act as adaptive immune systems by generating and maintaining an
immunological memory of infection (Figure 1-1) (Barrangou et al., 2007). The CRISPR
operon is located on the host chromosome or a host plasmid and is composed of a
CRISPR array and CRISPR-associated genes. CRISPR arrays are composed of direct
repeat sequences, ~30 base pairs long, separated by spacer sequences, which are also
roughly 30 base pairs long (Bolotin et al., 2005). The spacer sequences serve as the
genetic memory of infection (Makarova et al., 2006).
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Figure 1-1
CRISPR-Cas Systems are Adaptive Immune Systems

Note. These systems defend against mobile genetic elements such as phage through adaptation,
biogenesis, and interference stages.
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CRISPR systems generate immunity in stages (Carter & Wiedenheft, 2015). The
first stage, adaptation, occurs when the CRISPR adaptation complex, Cas1-Cas2,
recognizes, processes, and integrates foreign nucleic acid sequences into the CRISPR
array adjacent to the leader sequence. The result of integration is a new spacer sequence
and thus, a new memory of infection (Yosef et al., 2012; Nuñez et al., 2015; Xiao et al.,
2017). Interestingly, integration of new spacer sequences occurs near the leading direct
repeat sequence. This means a more recent infection can be identified from an older
infection (Held et al., 2010; Yosef et al., 2012). This information allows for a more
thorough understanding of contemporary threats.
CRISPR RNA (crRNA) biogenesis defines the second stage. The CRISPR operon
is transcribed, resulting in Cas proteins and a long pre-crRNA sequence. The long precrRNA is processed into shorter guide RNA (gRNA) sequences by either Cas or host
nucleases (Haurwitz et al., 2010; Charpentier et al., 2015). Next, Cas proteins assemble
on the crRNA, comprised of a truncated direct repeat and a spacer sequence, to form a
ribonucleoprotein complex (RNP) capable of surveilling the cell for complementary
nucleic acid (Brouns et al., 2008; Charpentier et al., 2015).
After RNP complex assembly, the CRISPR-Cas system enters the interference
stage of immunity. RNP complexes will probe the cell matrix for foreign nucleic acid
targets by examining the complementarity of DNA or RNA sequences to the gRNA. This
surveillance process is enhanced through complex recognition of a protospacer adjacent
motif (PAM) on the foreign nucleic acid. PAM sequences are usually only 3-5
nucleotides in length and act as a self vs. non-self label (Marraffini & Sontheimer, 2010).
If the RNP complex recognizes the PAM, complementarity between the gRNA and the
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bound nucleic acid will be probed (Mojica et al., 2009; Shah et al., 2013; Sternberg et al.,
2014; Gleditzsch et al., 2018). If sufficient complementarity exists, targeting will occur
via a cleavage event by either the RNP complex or a recruited nuclease. This cleavage
event will destroy the bound target sequence, inhibiting a given mobile genetic element
from propagating throughout a microbial community (Brouns et al., 2008; Marraffini &
Sontheimer, 2008; Hille et al., 2018).
CRISPR-Cas systems utilize a diverse array of enzymes and differ in their crRNA
processing, target substrate preference (DNA/RNA), and the mechanism of target
substrate interference. The classification of systems is based on the structure and gene
contents of the system. Two classes and six sub-types are used to classify and categorize
these systems. Class 1 systems (types I, III, and IV) are composed of multi-subunit RNP
complexes. In contrast, class 2 systems (types II, V, VI) are composed of single subunit
RNP complexes (Figure 1-2). The six types of CRISPR-Cas systems are divided into ~50
subtypes, with new subtypes being identified yearly (Makarova et al., 2015; Makarova et
al., 2019; Koonin & Makarova, 2022).
Class 1 CRISPR-Cas systems describe large multi-subunit RNP complexes. There
are three class 1 CRISPR systems (I, III, and IV). Type I and type III systems are
composed of a multi-protein complex called Cascade (CRISPR-associated complex for
antiviral defense). These RNP complexes contain multiple Cas7 backbone proteins, a
Cas6/Csf5 subunit, a large subunit Cas8/Cas10 and then Cas11, which act as small
subunits (Jackson et al., 2014; McMahon et al., 2020). Cas6/Csf5 is used by type I and
type III systems to process the long pre-crRNA into a shorter crRNA during biogenesis
(Carte et al., 2010; Barrangou, 2013; Charpentier et al., 2015). Type I systems bind
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Figure 1-2
CRISPR-Cas Immune Systems are Diverse

Note. Class 1 Systems form multiprotein complexes. The CRISPR Cascade complex
from the Type I systems is represented in the diagram. Class 2 systems form a single
protein complex. The CRISPR Cas9 complex is represented in the diagram.
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double-stranded DNA (dsDNA) and recruit the cas3 helicase/nuclease to unwind and
degrade dsDNA (Sinkunas et al., 2011; Mulepati & Bailey, 2013; Jackson et al., 2014;
Mulepati et al., 2014; van Erp et al., 2015; Xiao et al., 2018). Type III systems bind
RNA, while the cas10 subunit in these systems will bind and cleave ssDNA and RNA
(Hale et al., 2009; Staals et al., 2013; Tamulaitis et al., 2014). Type IV systems contain
CRISPR-cas subtype as in A. ferrooxidans genes (csf) csf1, csf2, csf3, and csf5. They are
adjacent to type IV accessory genes (dinG, cysH, and cas10-like) and form RNP
complexes (Taylor, 2021; Özcan et al., 2018; Zhou et al., 2021). These systems have
been shown to disrupt plasmid transformation efficiencies and interfere with gene
expression without DNA nuclease activity (Crowley et al., 2019; Guo et al., 2022).
However, little is understood about the type IV systems and the mechanisms they use to
interfere with MGE.
Class 2 CRISPR-Cas Systems describe single subunit RNP complexes. There are
three class 2 CRISPR systems (II, V, and VI). Type II systems utilize Cas9-like proteins,
recognize guanine-rich PAM sequences, and cleave DNA adjacent to the PAM using an
HNH and RuvC-like domain, producing blunt double-stranded DNA breaks (Garneau et
al., 2010; Gasiunas et al., 2012; Jinek et al., 2012). Type V systems utilize Cas12a-like
proteins, recognize thymine-rich PAM sequences, and cleave distally to the PAM using a
single RuvC-like domain resulting in staggered double-stranded DNA breaks (Zetsche et
al., 2015). Type VI systems utilize Cas13-like enzymes, do not have a set PAM but may
use a protospacer flanking sequence (PFS) for initial recognition and then bind and
cleave single-stranded RNA (Abudayyeh et al., 2016).
In chapter 2 of this thesis, I discuss my work on the least understood CRISPR
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type, the type IV-A CRISPR system and the CRISPR associated protein, CasDinG, and
its role in CRISPR immunity. I show evidence that CasDinG acts as a 5’-3’ ATPdependent helicase and present the first crystal structure of a type IV-associated helicase.
Furthermore, mutational analysis of this protein highlights accessory domains that are
essential for helicase, ATPase, and in vivo function. This work is significant as it
provides key insight into the interference mechanism of type IV-A immune systems
which have been presumed to utilize helicase activity, but this work is the first to prove
CasDinG helicase function. Knowledge of how type IV-A systems utilize helicase
activities could provide new insight into another aspect of how immune systems use
helicases as means of thwarting mobile genetic element infections.
In chapter 3 of this thesis, I discuss the foundational work I performed on the
class 2 single-subunit type V-A2 Cas12a2 proteins. I provide evidence showing that
Cas12a2 processes its own crRNA guide through the use of lysine and arginine residues
which were identified using a structure prediction model. I show preliminary evidence
that Cas12a2 can bind and cleave nucleic acid. Furthermore, my work on these systems
resulted in a low-resolution cryo-electron microscopy map from which some structural
analyses could be made. This work was significant as it provided the first proof that
Cas12a2 could process a crRNA for use as a guide RNA, fulfilling the second essential
step for CRISPR immunity. Additionally, my work provided the foundation for
collaborators and fellow lab members to identify the interference mechanism of Cas12a2.
Overall, the research performed on Cas12a2 may lead to the development of a new
CRISPR-Cas tool capable of acting as a diagnostic or as tool in gene therapeutics or
cancer treatment (Dymetrenko et al., 2022). Some of my work on SuCas12a2 was
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included in a manuscript currently under revision in the journal Nature, of which I am
listed as a co-author.

Wadjet Defense Systems
Bioinformatic analysis of defense islands and known prokaryotic immune systems
resulted in the identification of 28 phylogenetically distinct immune systems. One of
these systems, Wadjet, was found to limit plasmid transformation efficiency in B. subtilis
(Doron et al., 2018). How this system disrupted plasmid transformation efficiency is
unknown. Furthermore, there is no other biochemical or structural data in the current
literature which describes Wadjet systems.
Structure prediction software showed that Wadjet systems share structural
similarities with the E. coli MukBEF chromosome condensin complex proteins (Doron et
al., 2018). Condensin complexes bind, condense, and segregate nucleic acid as it is
replicated in the cell during mitosis (Hirano, 2012). Knowledge of a condensin-like
system, such as Wadjet, could provide powerful insight into how bacteria regulate
horizontal gene transfer of plasmids or manage the replication of plasmids. Additionally,
it is unknown whether Wadjet systems can target other nucleic acids, such as singlestranded phage as this was not tested in the initial in vivo studies involving Wadjet
systems. Furthermore, B. Subtilis utilizes a plasmid transformation strategy in which the
plasmid is integrated into the host as single-stranded DNA, thus whether Wadjet systems
recognize ssDNA or dsDNA (plasmid) is unknown (Yadav et al., 2012).
In chapter 3 of this thesis, I discuss cloning of the Wadjet genes, jetABC, from
two prokaryotic species, Azotobacter vinelandii DJ and Mycobacterium MCS, into
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ligation-independent expression vectors and show evidence that AvJetB is recombinantly
expressed and purified as a dimer. My work on these Wadjet systems provides the
preliminary work necessary to study these systems in vitro and is significant as the
dimerization of JetB supports the hypothesis that Wadjet systems share similarities with
condensin systems which form dimeric complexes. Studies of condensins and condensinlike systems can provide powerful insight into nucleic acid segregation, without which
cells die (Hirano, 2016).
Chapter 4 of this thesis discusses a summary of the Wadjet and type IV-A and
type V-A2 CRISPR-Cas immune system projects. This summary includes a brief
discussion of the biochemical research performed as well as future directions for each
project.
Basic research on novel prokaryotic immune systems allows for the identification
of tools used by microbes to manipulate nucleic acids and defend against infectious
events. Determining biochemical parameters surrounding protein-protein and proteinnucleic acid interactions results in a foundation of knowledge that promotes genome
editing research, medical research, and recombinant nucleic acid technology which can
lead to treatments for genetic disease and repurposed biotechnological tools (Cho et al.,
2013; Cong et al., 2013; Mali et al., 2013).
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CHAPTER 2
CASDING IS A 5’- 3’ ATP-DEPENDENT HELICASE

Abstract
Pseudomonas aeruginosa strain 83 encodes a type IV-A CRISPR-Cas system that
relies on five genes (csf1, csf2, csf3, cas6, and dinG) and a CRISPR array to protect
against invasive plasmids. Phylogenetic analysis shows that type IV-A CRISPRassociated DinG (CasDinG) is distinct from chromosomally associated DinG proteins
which are helicases involved in recombination and repair. This distinction suggested that
CasDinG may play a CRISPR-specific role in type IV-A immunity. This thesis contains
biochemical and structural analyses essential for understanding CasDinG function. We
provide the first structure of a type IV CasDinG helicase using x-ray crystallography.
Fluorescence anisotropy techniques were used to determine binding affinities to nucleic
acid substrates. Colorimetric ATPase assays monitored the hydrolysis of adenosine
triphosphate in the presence of nucleic acids and helicase assays determined the preferred
directionality of strand displacement. Furthermore, in vitro and in vivo mutational
analysis of domains and motifs provided functional insight into the role of CasDinG as a
CRISPR-associated helicase.

Introduction

Type IV CRISPR-Cas Systems
Type IV biochemical mechanisms and structures remain largely uncharacterized,
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as large complexes can be challenging to study via recombinant expression and
purification techniques. Work in recent years has shown that type IV systems form multisubunit RNP complexes, process guide RNAs, and can reduce the transformation
efficiencies of target plasmids (Özcan et al., 2018; Crowley et al., 2019; Taylor et al.,
2019; Zhou et al., 2021). Type IV systems are found almost exclusively on plasmids and
are not typically associated with adaptation machinery or identifiable nucleases
(Makarova et al., 2017, 2019; Pinilla-Redondo et al., 2019). The mechanisms behind how
these systems acquire new spacers, enact interference, and whether they recruit or
assemble with associated proteins is unknown.
There are three subtypes of type IV CRISPR-Cas systems (A, B, & C) (Makarova
et al., 2020; Taylor et al., 2021). Type IV-A systems lie adjacent to dinG-like genes and
are commonly adjacent to CRISPR arrays. Type IV-B systems lie adjacent to cysH-like
genes and are not found adjacent to CRISPR arrays and type IV-C systems lie adjacent to
cas10-like genes and may or may not lie adjacent to CRISPR arrays (Taylor et al., 2021).
Many type IV systems are found on plasmids and contain spacer sequences that target
plasmids, suggesting that these systems may play a role in inter-plasmid warfare (PinillaRedondo et al., 2019). Because some type IV systems lack the adaptation genes cas1 and
cas2, it is theorized that these systems rely upon other CRISPR-Cas systems found in
their hosts, such as the type I-E system, to generate new spacer sequences (PinillaRedondo et al., 2019). Due to the lack of identifiable nuclease genes close to or within
type IV-A and type IV-B systems, there is speculation on how interference occurs.
Perhaps endogenous host nucleases are recruited, there are unidentified nuclease motifs,
or interference occurs on a transcriptional level.
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Out of the type IV systems, the most studied are the type IV-A systems which
have been shown to process a long pre-crRNA into shorter guide RNA sequences and
inhibit plasmid transformation recombinantly (Crowley et al., 2019; Taylor et al., 2019).
It was recently reported that there is inhibition of gene expression without the cleavage of
DNA. This indicates that type IV-A systems may utilize gene repression or transcription
interference techniques to combat phage or plasmid (Guo et al., 2022). Whether the type
IV-A systems house unidentified nuclease motifs or recruit nucleases to cleave sequences
bound by the RNP has yet to be discovered. Furthermore, there are no solved structures
of the type IV-A complex or the associated CasDinG protein.

Pseudomonas aeruginosa type IV-A CRISPR-Cas
The type IV-A CRISPR-Cas system in Pseudomonas Aeruginosa strain 83 is
located on a plasmid and is composed of four cas/csf genes (csf1, csf2, csf3, cas6), the
dinG-like gene (casdinG), and a CRISPR array (Figure 2-1). Hannah Taylor, a graduate
student of the Jackson lab, has shown via recombinant expression and purification that
the type IV-A RNP complex is composed of csf1, csf2, csf3, and cas6 in a predominantly
1:2:1:1 ratio. This ratio was confirmed by mass spectrometry; however, alternative ratios
were also identified (Taylor et al., 2021). Initial in vivo characterization was performed
by Dr. Val Crowley using both plasmid competition and plasmid curing assays. Omission
of any type IV-A RNP genes leads to a non-functional CRISPR immune system
incapable of targeting complementary nucleic acid. Omission of the casdinG gene or
mutation of the Walker B DEAH motif also leads to a non-functional immune system,
showing that the binding or hydrolysis of ATP is essential for CasDinG function

25
(Crowley et al., 2019). Herein lies a fundamental question which is, what is the role of
CasDinG in type IV-A immunity and what does ATP have to do with it?

CasDinG and Non CasDinG Helicases
Helicases are enzymes that remodel nucleic acid through the hydrolysis of
nucleotide triphosphates (NTPs) and are categorized based on shared sequence motifs.
There are six superfamilies of helicases, superfamilies I and II are typically monomeric,
families III-VI are typically hexameric and helicases from all families contain RecA-like
folds which house motifs important for NTP and nucleic acid binding (Pyle, 2008).
Superfamily II (SF2) proteins, house subfamilies of helicases which contain superfamily
II (SF2) helicase motifs: Q, I, Ia, Ib, Ic, II, III, IV, V, VI (Singleton et al., 2007; Pyle,
2008; Umate et al., 2011). These motifs are essential for ATP binding/hydrolysis, nucleic
acid binding/unwinding, and are typically located at the interface of the RecA1 and
RecA2 lobes (Tuteja & Tuteja, 2004; Pyle, 2008). In many cases, the hydrolysis of ATP
provides the chemical energy needed to generate the mechanical energy used to drive
protein conformational changes. These protein conformational changes result in the
remodeling of nucleic acid (Ye et al., 2004). These protein conformational changes can
result in translocation along single-stranded or duplexed nucleic acids with or without
unwinding. However, helicases can also remodel nucleic acid without translocation by
generating sufficient distortion in a nucleic acid strand to displace duplexes (Pyle, 2008).
Not all proteins categorized within helicase families are active helicases but have adopted
alternative roles requiring DNA binding, such as nuclease activity (McRobbie et al.,
2012). Characterization of helicases is typically performed by determining ATP
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hydrolysis rates, step size, binding requirements, whether accessory proteins are used or
needed, and whether there are directionality or polarity restraints (Pyle, 2008).
Helicases associated with CRISPR-Cas systems have been limited to the type I
systems that utilize the helicase/nuclease Cas3 during adaptation and interference
(Sinkunas et al., 2011). During interference, Cas3 is recruited to target bound Cascade
complex where it will nick the R-loop formed between the RNP complex and duplexed
nucleic acid and then degrade the DNA as it unwinds in a 3’-5’ direction (Sinkunas et al.,
2011; Westra et al., 2012; Mulepati & Bailey, 2013). The degradation of DNA by Cas3
will then enhance primed adaptation allowing for increased uptake of new spacer
sequences (Datsenko et al., 2012). Phylogenetic analysis of Cas3 proteins from archaea
and bacteria shows conservation of SF2 family helicase motifs and inclusion of a nonSF2 conserved asparagine in motif IV (Jackson et al., 2014).
DinG stands for damage-inducible gene and was identified in connection with
DNA-damage response pathways. DinG genes belong to the XPD family of SF2
helicases (Lewis & Mount, 1992; Koonin, 1993). XPD is a 5’-3’ ATP-dependent
eukaryotic helicase component in the transcription factor IIH complex and relies on an
iron-sulfur (FeS) cluster for helicase activity (Liu et al., 2008). FeS clusters found within
helicases, nucleases, and primases are essential for a variety of purposes, including
structural stability, DNA damage sensing, DNA binding, helicase activity, exonuclease
activity, and the formation of active protein complexes (Ren et al., 2009; White, 2009;
Yeeles et al., 2009; Netz et al., 2011; Stiban et al., 2014; Baranovskiy et al., 2018;
Mariotti et al., 2020). Characterization of XPD, Rad3, and multiple DinG homologs show
a dependence on iron-sulfur clusters for helicase activity (Rudolf et al., 2006; Pugh et al.,
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2008; Ren et al.,2009; Thakur et al., 2014).
For the purposes of this thesis, there are two classes of DinG enzyme: CRISPRassociated DinG (CasDinG) and non-CRISPR-associated DinG (non-CasDinG).
Bioinformatic analysis has shown that CasDinG are phylogenetically distinct from
chromosomally associated DinG helicases or non-CasDinG (Taylor et al., 2021).
Meaning, CasDinG amino acid sequences are more similar to one another than they are to
non-CasDinG DinG sequences, suggesting that CasDinG proteins may play a role unique
to CRISPR-Cas immune system function.
To date there are two types of non-CasDinG enzymes that have been
characterized. The first is the FeS domain-containing species, the most well studied from
Escherichia coli. E. coli DinG is a 5’-3’ ATP-dependent helicase implicated in DNA
repair and replication pathways (Voloshin et al., 2003; Voloshin & Camerini-Otero,
2007). E. coli DinG contains a Walker A and B motif housed between the RecA1 and
RecA2 domains. The structurally essential FeS domain is positioned between the Walker
A and B motifs, from N to C termini, as an accessory to the RecA1 domain, similar to the
XPD helicase (Cheng & Wigley, 2018). The second type of non-CasDinG is the nuclease
domain-containing DinG from Staphylococcus aureus. S. aureus DinG is a 3’-5’ ATP
tunable exonuclease and contains a large N-terminal exonuclease domain followed by a
RecA body containing Walker A and B motifs. This enzyme does not contain a FeS
cluster, or FeS containing domain and does not possess identifiable helicase activity
(McRobbie et al., 2012).
Comparison of the amino acid sequences of CasDinG to Non-CasDinG shows no
conservation of an exonuclease domain and no conservation of the cysteine residues
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necessary for coordination of an FeS cluster but does show conservation of the Walker A
and Walker B motifs (Figure 2-1; A-9; A-10). The lack of cysteine residues and structural
knowledge of fold similarities led to the renaming of FeS domain in CasDinG to the
vestigial FeS domain. A closer examination of Pa83 CasDinG amino acid sequences to
the S. aureus and E. coli non-Cas DinG homologs shows low identity and similarity
scores using EMBOSS needle pair-wise alignments. The highest alignment scores are
18.9% identity and 30.3% similarity with E. coli DinG (Figure A-9). These low similarity
and identity scores are common among SF2 helicases as these types of enzymes are
incredibly diverse in function. Typically, the similarity and identity scores reflect the
maintenance of highly conserved helicase motifs, whereas the regions between motifs are
variable, allowing for diversity in protein function (Fairman-Williams et al., 2010). With
this knowledge, the lack of a typical FeS domain and an N-terminal exonuclease domain
alongside the knowledge that CasDinG is a necessary component of type IV-A targeting
suggest that CasDinG may perform a function specific to CRISPR immunity (Crowley et
al., 2019). Furthermore, Alphafold and Robetta structure predictions of CasDinG show a
model with an N-terminal fold and a vestigial FeS domain (vFeS) that lacks the cysteines
needed to coordinate Fe atoms but maintains an ordered alpha-helical conformation
(Figure A-7) (Baek et al., 2021; Mirdita et al., 2022).
This thesis contains both in vitro and in vivo biochemical studies assessing the
biological role of CasDinG. Knowing that CasDinG contains nucleic acid and ATP
binding motifs. Nucleic acid binding assays, ATPase assays, helicase assays, and plasmid
curing assays were performed to elucidate functional roles of CasDinG. To understand
the function of CasDinG, the molecular structure was solved using x-ray crystallography,
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Figure 2-1
CasDinG is Distinct from Non-CasDinG

Note. A. Schematic comparing CasDinG domain organization from P. aeruginosa 83 to
Non-CasDinG from both E. coli and S. aureus. B. Operon schematic of the type IV-A
CRISPR-Cas system genes, composed of a CRISPR array, csf5, csf1, csf2, csf3, and
casdinG.
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allowing us to gather structural insight into how a non-FeS coordinating enzyme can
unwind nucleic acids.

Methods

Cloning & Gene Alignments
As described in a previous publication, the dinG gene from P. aeruginosa 83 was
synthesized by TWIST bioscience and cloned into a pET StrepII TEV ligation
independent cloning (LIC) vector (2R-T) vector (Crowley et al., 2019). Mutants were
generated using the Q5 Mutagenesis kit (NEB Biolabs). Decisions on where to mutate
domains were based on a predicted model of the CasDinG structure generated by Robetta
prediction software. It should be noted that mutations were first generated as a broad
means of identifying regions of activity (Figure A-7). For a list of constructs generated,
see Table A-3; for primers, see Table A-5.
Clustal Omega Alignments and EMBOSS NEEDLE pair-wise alignments E. coli
(P27296) and S. aureus (Q2FGY5) DinG sequences were obtained through the Uniprot
database server and aligned to Pa83 CasDinG using the Clustal Omega multiple sequence
alignment tool (McWilliam et al., 2013). Pairwise sequence alignments were performed
between Pa83 CasDinG and E. coli/S. aureus sequences using an EMBOSS Needle
alignment (Madeira et al., 2022).

Expression & Purification of CasDinG
The cloned vector containing the dinG gene from Pseudomonas aeruginosa 83
NCBI ref: WP_088922490.1 was transformed into Escherichia coli BL21 HMS174
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(DE3) chemically competent cells (Novagen). This cell line provides a RecA mutation in
an E. coli K-12 background, supposedly this strain can genes whose protein products may
cause loss of the DE3 prophage. From the transformation plate, a colony was picked and
placed into an overnight outgrowth. 1 L of Luria-Bertani (LB) medium in a 2.8 L flask
was inoculated with 1 mL of both 1000 x metals mix (0.1 M FeCl3-6H2O, 1 M CaCl2, 1
M MnCl2-4H2O, 1 M ZnSO4-7H2O, 0.2M CoCl2-6H2O, 0.1 M CuCl2-2H2O, 0.2M NiCl26H2O, 0.1 M Na2MoO4-2H2O, 0.1 M Na2SeO3-5H2O, 0.1 M H3BO3) and 1000 x 1 M
MgSO4 (Studier, 2015). The supplemented medium was then inoculated with the
overnight starter, and cells were grown to an optical density between 1.0 - 1.3 OD600 at
37 °C. When OD was reached, the cells were induced with 0.5 mM IPTG (isopropyl BD-1-thiogalactopyranoside), and the temperature was dropped to 20 °C for 5 hours. The
cells were then harvested via high-speed centrifugation and stored at -80 °C. All mutants
were expressed in the same manner.
Cells were homogenized on ice with lysis buffer (100 mM Tris Base pH 8.0, 150
mM NaCl, 1 mM TCEP (tris(2-carboxyethyl) phosphine)). The protease inhibitors
Aprotinin 1000 x (0.5 mg/mL), Leupeptin 1000 x (0.5 mg/mL), Pepstatin A 1000 x (0.7
mg/mL), & PMSF 150 x (25 mg/mL) were added prior to cell lysis. Probe sonication for
cell lysis was performed at settings of 4/60. The lysate was clarified by high-speed
centrifugation at 16 K RPM for 30 minutes.
All purification steps were performed at 4 °C. The supernatant was loaded onto
strep resin (Strep-Tactin®XT 4Flow®, IBA). The resin was washed with lysis buffer and
then eluted with elution buffer (100 mM Tris Base, 150 mM NaCl, 50 mM Biotin, 1 mM
TCEP, pH 8.0). Fractions with DinG were pooled. Protein was loaded onto a desalting
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column (HiPrep 26/10 Desalting, GE Healthcare) that had been pre-equilibrated with low
salt buffer (100 mM Tris Base pH 8.0, 10 mM NaCl, 1 mM TCEP), and then DinG
fractions were run over the column. Protein elution was collected and then run over a
heparin column (HiTrap Heparin HP, GE Healthcare). The column was washed with 47.5
mM NaCl buffer. The protein was eluted into a high salt buffer (100 mM Tris Base pH
8.0, 500 mM NaCl, 1 mM TCEP). Samples were spun down using a spin concentrator
(Corning® Spin-X® UF 50 MWCO) before placement on a size exclusion column
(HiLoad 26/600 Superdex 200 pg., GE Healthcare). Protein was eluted off of the size
exclusion column into the high salt buffer (100 mM Tris Base pH 8.0, 500 mM NaCl, 1
mM TCEP). Protein samples were concentrated and stored at 4 °C, as freezing at -80 °C
resulted in loss of activity. All mutants were purified in the same manner. Protein was
assessed for purification after each step via 12% SDS-PAGE.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), using the Beer-lambert law to correct absorbance values for
extinction coefficient (assuming all cysteines are reduced) and molecular weight as
determined by Expasy Protparam (Table A-6).

Western Blots
Western blots were performed using the Pierce Fast Western Blot kit from
ThermoFisher Scientific (catalog #35055). The standard protocol was altered by
increasing the time the primary antibody working dilution was incubated with the blot.
The length of time was increased from 30 minutes at room temperature to 60 minutes at
room temperature. The Precision Plus Protein™ WesternC™ Blotting Standards (Biorad,
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#1610376) were also utilized. The Strep-Tactin conjugated HRP antibodies were
sufficient for both the ladder and the strep-tagged protein samples.

Crystallization and Structure determination
The purified recombinant strep-tagged CasDinG protein was concentrated at 5
mg/ml and crystallized using 0.225 M Imidazole pH 8.0, 3.5 % PEG8000, and 30 %
sucrose using hanging-drop vapor diffusion at room temperature. The crystal used for
structure determination was comprised of 1 µL (5mg/ml) protein solution to 2.6 µL
mother liquor and 0.4 µL 30 % sucrose. The crystal was then soaked in a cryoprotecting
solution composed of 30 % ethylene glycol and mother liquor, then mounted on a loop
and cooled to 100 K. Diffraction data were collected at the SSRL beamline 9-2. The data
were indexed, integrated, and scaled using HKL3000. A data set to 2.95 Å was recorded
with the space group determined as P65. Alphafold structure predictions were generated
using the google colab Alpha 2.0 servers to solve the phases through molecular
replacement (Mirdita et al., 2022). The motor domains of these structure predictions were
then used as the starting models in Phenix for phasing, for a more in-depth explanation of
molecular replacement using an Alphafold model see Appendix A, Supplemental
Methodology. Model building was performed in COOT, the structures were refined using
PHENIX, and validation was performed using Molprobity within PHENIX and the PDB
deposition servers (Emsley et al., 2010; Liebschner et al., 2019).

Nucleic Acid Substrate Preparation
Nucleic acids were synthesized by Integrated DNA Technologies (IDT). Nucleic
acids were labeled with a fluorescein (FAM) label on the 5' and 3’ end by IDT. To make

34
duplexed nucleic acids, complementary oligonucleotides were mixed in an equimolar
ratio in the presence of NEB buffer 2.1 and heated to 95°C. These oligonucleotides were
slowly cooled to room temperature before being run on 12-15% native PAGE gels.
Duplex bands were then gel extracted, ethanol precipitated, and reconstituted in water.

Nucleic acid-binding assays
Nucleic acid-binding activities of strep-tagged CasDinG were monitored using a
fluorescence polarization-based assay. Anisotropy data were collected using a BioTek
Synergy H4 Hybrid Multi-Mode Microplate Reader equipped with polarizers and
bandpass filters. The polarizers and bandpass filters provided 485 ±20 nm excitation and
detection of fluorescence emission at 528 ± 20 nm. Each reaction (80 µL) contained a
limiting concentration (10 nM) of 5’ FAM-labeled nucleic acid substrate. CasDinG and
5’ FAM nucleic acid were assayed at room temperature with increasing concentrations of
CasDinG (0 – 2.5 µM) in a binding buffer (100 mM Tris pH 8.0, 1 mM TCEP, and 5 mM
MgCl2). Change in anisotropy relative to FAM-nucleic acid was plotted as a function of
CasDinG concentration. The apparent dissociation constant (Kd) for each nucleic acid
substrate was determined by fitting the raw data to a single site saturation binding model
in GraphPad Prism for Windows version 9.3.0. For a list of oligonucleotides used in these
assays, see supplemental Figure A-4 and Table A-4.

Malachite Green ATPase Assays
Concentrations of inorganic phosphate (Pi) were determined with a Malachite
Green Phosphate Assay kit (BioAssay Systems, Haward, CA, USA). Activated Malachite
Green reagent was added to wells of a 384 well plate (Corning Assay Plate, 384 wells,
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Black with clear bottom, non-binding surface, Low flange, no lid, polystyrene, 3766).
Before the reaction, assay components were incubated at 37 °C for 15 minutes. Reactions
were started with the addition of ATP run at 37 °C. The reaction was quenched in the
activated Malachite Green reagent at designated time points, between 30 - 150 seconds
for nucleic acid containing reactions and 0 - 4 minutes for basal reactions. The quenched
reactions were developed for 30 minutes before sample measurement. The absorbance
values of the samples were obtained using a Synergy H4 Hybrid Multi-Mode Microplate
Reader measuring absorbance at 620 nm.
The initial velocities of CasDinG nucleotide triphosphate hydrolysis were
determined in the presence of ssDNA (40 nt.) with 10 nM CasDinG, 100 nM nucleic
acid, and 600 µM nucleotide triphosphate (NEB) in the buffer (50 mM Tris pH 7.5, 0.1
mg/ml Recombinant Albumin, 1 mM MgCl2, 0.4 mM TCEP). Substrate comparison
initial velocities utilized 10 nM CasDinG, 100 nM nucleic acid, and 600 µM ATP, which
was reconstituted in lab and spectroscopically verified, in the buffer (50 mM Tris pH 7.5,
0.1 mg/ml Recombinant Albumin, 1 mM MgCl2, 1 mM TCEP). Structural mutants were
assayed for ATPase activity in the presence of single stranded DNA (40 nt.) using 20 nM
CasDinG and 200 nM ssDNA (40 nt.). Michaelis-Menten curves were generated for
CasDinG (20 nM) + single stranded phosphorothioated RNA (200 nM) pH 7.5, CasDinG
(10 nM) + single stranded DNA (100 nM) pH 7.5, CasDinG (18.5 nM) + single stranded
DNA (150 nM) pH 6.8 and ApoCasDinG pH 6.8 (500 nM). Michaelis-Menten reactions
at pH 7.5 utilized the buffer (50 mM Tris pH 7.5, 0.1 mg/ml Recombinant Albumin, 1
mM MgCl2, 1 mM TCEP) whereas reactions at pH 6.8 used the buffer (20 mM PIPES pH
6.8, 0.1 mg/ml bovine serum albumin (BSA), 50 mM NaCl, 1 mM TCEP, 5 mM MgCl2).
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For a list of oligonucleotides used in these assays, see supplemental Figure A-4 and Table
A-4. GraphPad Prism for windows version 9.3.0 fits the data set to the Michaelis-Menten
equation (Equation 1). Where v is the initial reaction velocity of the reaction, [S] is the
ATP concentration, KM is the Michaelis constant, and Vmax is the maximum velocity of
the enzyme.
Equation 1
𝜐= 𝑉max[𝑆]/𝐾𝑀+[𝑆].
ATP concentrations were spectroscopically verified at 280 nm with crystal
cuvettes and a spectrophotometer. Concentrations were confirmed using the BeerLambert law (Equation 2). Where A is the absorption, E is the extinction coefficient, l is
the path length, and c is concentration. The molar extinction coefficient for ATP was
15,400 M-1cm-1. ATP was frozen at -80°C, and aliquots were used and then discarded
after a single thaw.
Equation 2
A=εlc

Preparation of chemically competent type IV-A CRISPR Cas cells
Transformations were prepared using an open flame and standard aseptic
technique. BL21 HMS174 (DE3) E. coli cells (Novagen), thawed on ice and 50-100 ng of
both plasmid #1284(pCDF_Pa_csf1_csf2_cas6) and plasmid #1290(pACYC-PaCR83csf3-dinG),2367 (PACYC-PA83CR-csf3-dinG-NTerm-truncation),2368(PACYCPA83CR-csf3-dinG-ArchKO),2369 (PACYC-PA83CR-csf3-dinG-FeS-KO) or 2370
(PACYC-PA83CR-csf3-dinG-DEAH_AAAH-KO), were added to the cells. Cells were
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then heat shocked in a 42 °C water bath for 45 seconds, followed by a cold shock on ice
for 5 minutes. 450 μL of antibiotic-free LB broth was added to the cells, followed by a 1
hour incubation at 37 °C in a shaking incubator, 200 RPM. Cells were then plated on LB
agar containing streptomycin and chloramphenicol at 50 and 25 μg/mL concentrations,
respectively. Plates were then incubated at 37 °C for 16-24 hrs. LB broth containing
streptomycin and chloramphenicol (50 and 25 μg/mL, respectively) was incubated at
37 °C for 16-24 hrs. in a shaking incubator, 200 RPM in preparation for the next day.
Colonies from the overnight plates were used to inoculate 25 mL of the prepared
LB broth in a 50 mL falcon tube. These cells were then incubated at 37 °C until an OD600
between 0.2-0.3 when they were induced with 0.1 mM IPTG (100 µM IPTG). Cells were
allowed to grow for an additional 45 minutes at 37 °C before being cold-shocked on ice
for 20 minutes. Cells were then spun down at 2700 x G for 15 minutes at 4 °C. The
supernatant was decanted, and the cells were resuspended in 12 mL RF1 Buffer (100 mM
RbCl, 50 mM MnCl24H2O, 30 mM Potassium acetate, 15% m/v glycerol). Cells were
then allowed to rest on ice for 15 minutes before being spun down at 870 x G for 15
minutes. The supernatant was decanted, and cells were resuspended in 1 mL of RF2
Buffer (10 mM MOPS, 10 mM RbCl, 75 mM CaCl22H2O 15% m/v glycerol). Cell
solution was incubated on ice for 15 minutes prior to aliquoting cells in 100 µL volumes
and flash freezing at -80 °C.

In Vivo Plasmid Competition Assay
Using type IV-A CRISPR-Cas containing chemically competent cells, 10 ng of
target or non-target plasmid, #2380 (pET27b_CA01_GGAAA) and 1095 (pET27b(+)-
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non-target_TTTC) respectively, was added to a 100 µL cell aliquot. Cells were then heat
shocked at 42 °C for 30-40 seconds, followed by a cold shock on ice for 1-3 minutes. 400
µL of LB containing chloramphenicol 25 μg/mL, streptomycin 50 μg/mL, and 0.1 mM
IPTG were then added to the cold shocked cells. Cells were then incubated at 37 °C for
16-24 hrs. in a shaking incubator, 200 RPM, followed by plating of cells onto a triple
antibiotic LB agar selection plate (Chloramphenicol 25 μg/mL, streptomycin and
kanamycin 50 μg/mL, and IPTG 0.1 mM IPTG). The cells were then plated in rows of 6
with 10 µL volumes. A dilution series was performed and plated from left to right in
dilutions of 1, 10, 100, 1000, 10,000, and 100,000-fold. The inoculating drops were
allowed to dry and then placed in a 37 °C incubator for 24 hrs. Plates were imaged using
a Bio-Rad Imager with a non-stained blot setting. Colonies were then counted manually.

Helicase assays

Direct Substrate and Mutant Comparisons
15 nM 5' fluorescein (FAM) labeled nucleic acid was incubated in the presence of
100 nM WT CasDinG and 1 mM ATP in the helicase buffer (25 mM Tris pH 7.5, 1 mM
MgCl2, 1 mM TCEP, 0.1 mg/ml recombinant albumin) for approximately 20 minutes at
37 °C before being quenched in 2 x STOP buffer (10 mM EDTA
(Ethylenediaminetetraacetic acid), 1% SDS (Sodium Dodecyl Sulfate), 20% glycerol)
with 500 nM unlabeled displaced strand. Samples were run on 15% TBE native PAGE
gels. The mutant analysis utilized the same nucleic acid substrate as WT CasDinG and an
equivalent amount of protein.
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Direct NTP Comparisons
15 nM 5' FAM-labeled nucleic acid was incubated in the presence of 100 nM WT
CasDinG and 1 mM ATP analogue (ATP, ADP, ATPγS, and AMP-PNP) in the helicase
buffer (25 mM Tris pH 7.5, 1 mM MgCl2, 1 mM TCEP, 0.1 mg/ml recombinant
albumin) for approximately 20 minutes at 37 °C before being quenched in 2 x STOP
buffer with 500 nM unlabeled displaced strand. Samples were run on 15% TBE native
PAGE gels.

Metal Comparisons
15 nM 5' FAM labeled nucleic acid was incubated in the presence of 100 nM WT
CasDinG and 1 mM ATP and 1 mM divalent salt (MgCl2, MnCl2, ZnCl2, CaCl2, NiCl2,
CoCl2, CuCl2) in the helicase buffer (25 mM Tris pH 7.5, 1 mM TCEP, 0.5 mg/ml BSA)
for approximately 20 minutes at 37 °C before being quenched in 2 x STOP buffer with
500 nM unlabeled displaced strand. Samples were run on 15% TBE native PAGE gels.

Time Courses
15 nM FAM-labeled nucleic acid substrate was exposed to 25 nM CasDinG over
the course of 10 minutes in the presence of 1 mM MgCl2 and 1 mM ATP in the helicase
buffer (25 mM Tris pH 7.5, 0.1 mg/mL recombinant albumin, 1 mM TCEP) at 37 °C.
Samples were quenched in 2 x STOP buffer at times between 0-10 minutes and run on
15% TBE native PAGE gels. For a list of oligonucleotides used in these assays, see
supplemental Figure A-4 and Table A-4.

Gel Analysis
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All PAGE gels for helicase assays were imaged using a BioRad Imaging system
and analyzed using BioRad ImageLab software. Percent unwound were quantified using
ImageLab software, and reported data is the average of three experiments, with error bars
representing the standard deviation from the mean. Graphs were made in GraphPad Prism
for Windows version 9.3.0.

Type IV-A Complex (+/- CasDinG) Expression & Purification
The cloned vectors containing the type IV-A complex (csf1, csf2, csf3, cas6, and
the CRISPR array) and casdinG (No tag sequence) were transformed into Escherichia
coli BL21 HMS174 (DE3) chemically competent cells (Novagen). The NCBI reference
codes are WP_088922490.1 (CasDinG protein sequence) and NZ_CP017294.1 (Pa83
plasmid sequence) To obtain the genes for the type IV-A complex refer to the plasmid
sequence. This protocol can be used either for just RNP complex purification or RNP +
CasDinG purification. From the transformation plate, a colony was picked and placed
into a 25 mL overnight outgrowth. 1 L of LB medium in a 2.8 L flask was supplemented
with 1000 x Metals Mix and 1000 x MgSO4 (Studier, 2015). The media was then
inoculated with a 20 mL overnight starter. Cells were grown to an optical density
between 1.0-1.3 OD600 at 37 °C 200 RPM in a shaking incubator. When OD600 was
reached, the cells were induced with 0.5 mM IPTG, and the temperature was dropped to
20 °C for 5 hours. The cells were then harvested via high-speed centrifugation and stored
at -80 °C.
Cells were homogenized on ice with 35 mL lysis buffer (100 mM Tris base pH
8.0, 150 mM NaCl, 1 mM TCEP). The protease inhibitors 1000 x Aprotinin (0.5mg/mL),
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1000 x Leupeptin (0.5 mg/mL), and 1000 x Pepstatin A (0.7 mg/mL) were added prior to
cell lysis. Probe sonication for cell lysis was performed at settings of 4/60 for eight
minutes. The lysate was then clarified by high-speed centrifugation at 16 K RPM for 35
minutes.
All purification steps were performed at 4 °C. The supernatant was loaded onto a
nickel column (HisTrap HP, GE Healthcare) that had been pre-equilibrated with lysis
buffer. The column was washed with wash buffer (100 mM Tris pH 8.0, 500 mM NaCl,
150 mM Imidazole, 1 mM TCEP) and then with lysis buffer. The protein sample was
then eluted with Ni elution buffer (100 mM Tris pH 8.0, 150 mM NaCl, 1 M Imidazole, 1
mM TCEP). Fractions with complex were pooled. The sample was then run over strep
resin (Strep-Tactin XT 4 Flow, IBA). The column was washed with lysis buffer followed
by protein elution using the strep elution buffer (100 mM Tris base pH 8.0, 150 mM
NaCl, 50 mM Biotin, 1 mM TCEP), which was allowed to incubate with the resin for 15
minutes prior to sample collection. Eluted samples containing protein were spun down
using a spin concentrator (Corning® Spin-X® UF 100 MWCO) for placement on a size
exclusion column (Superdex 200 10/300 GL, GE Healthcare). Protein was eluted into a
final buffer (100 mM Tris pH 8.0, 150 mM NaCl, 1 mM TCEP) using the sizing column.
Protein samples were then concentrated and stored at 4 °C for use or flash frozen at 80 °C.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), and the appropriate extinction coefficient was applied as determined
by Expasy Protparam, assuming a 1:2:1:1, Csf1:Csf2: Csf3:Csf5/Cas6 ratio of purified
type IV-A RNP complex (Table A-3).
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Far- UV Circular Dichroism (CD)
Far- UV CD spectra were collected for strep-tagged WT CasDinG,
∆DEAH_AAAH, and ∆N. terminal truncation in a low salt buffer (100 mM Tris pH 8.0,
10 mM NaCl, 1 mM TCEP). All data were collected using a JASCO model J-1500
spectropolarimeter. CD spectra were collected from 190 to 260 nm at 10°C using 0.1 cm
quartz cuvettes, 0.3-1 nm data sampling, a 50 nm/min scan rate, and a 1 second data
integration time. Measurements were performed at 0.5 mg/mL protein concentration, and
CD signals were normalized by converting to mean residue molar ellipticity. WT and
∆DEAH_AAAH were collected in triplicate with the average values plotted. ∆Nterminal truncation was collected once.

Plasmid Cleavage Assay
Target (GGAAA PAM sequence) and non-target plasmid were held at 120 ng
concentration in a 10 µL reaction containing 5.37 µM type IV-A RNP complex, 100 nM
DinG (WT), and 1 mM ATP in a reaction buffer (25 mM Tris pH 7.5, 1 mM MgCl2, 1
mM TCEP, 0.1 mg/ml recombinant albumin) for 50 minutes at 37 °C before being
quenched in a 2 x STOP buffer. Samples were run on a 1 % agarose gel.

Results

Protein Purification
To assess the function of CasDinG, we recombinantly expressed the Pa83
CRISPR associated dinG gene (NCBI ref: WP_088922490.1) using E. coli HMS174
(DE3) cells and confirmed the expression of the strep tagged 81.1 kDa protein using
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Figure 2-2
Purification of CasDinG

Note. A. Western blot showing expressed strep-tagged CasDinG from cell pellets
using strep-tactin antibodies. B. Size exclusion chromatogram showing streptagged WT CasDinG (81.1 kDa) with UV absorption at 280 and 253 nM
respectively off a Superdex 200 pg. 26/600 column. A representative 12 % SDS
PAGE gel, stained with Coomassie blue, showing purified protein is below the
curve.
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western blots. Analysis of size exclusion chromatograms were consistent with the elution
of a monomeric CasDinG species (Figure 2-2).

Crystallization and structure determination
To truly understand the mechanism of CasDinG, the first crystal structure
of CasDinG was solved at a resolution of 2.95Å (Table 2-1; Figure 2-3). The phases of
the x-ray crystal data were solved by using an Alphafold structure prediction model for
molecular replacement. The solved model shows a core composed of a RecA-like
helicase core and two accessory domains.
Electron density became apparent at amino acid position 104, indicating that the
N-terminus is flexible. Alphafold structure predictions of CasDinG showed variability in
the positioning of the N-terminus, supporting the hypothesis that the N-terminus is
flexible. Two of the accessory domains, the arch and vestigial FeS (vFeS), were resolved
and are located as inserts into the RecA1 lobe. There are 11 helicase motifs that can be
identified in the RecA body, which allow us to infer from the structure that this is a
nucleic acid and NTP binding enzyme, similar to other DinG proteins (Figure A-8).
Alignment of the CasDinG model with the solved structure of E. coli DinG bound to
single-stranded DNA, PDB 6FWR, shows conservation of a nucleic acid binding pocket
within the RecA-like cleft (Figure 2-3). Comparison of the arch domains between
homologs shows that the arch from CasDinG is composed of fewer amino acids but the
overall architecture of the domain is conserved, although the CasDinG structure lacks a
β-loop between alpha helices two and three (Figure 2-4; Figure 2-5). Analysis of the
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Table 2-1
CasDinG Data Collection and Refinement Statistics
Dataset

Native

Data collection
Beamline
SSRL 9-2
Space group
P65
Cell dimensions
a, b, c (Å)
123.3, 123.3, 136.9
α, β, γ (deg)
90.0, 90.0, 120
Wavelength (Å)
0.88684
Resolution** (Å) 50-2.95 (3.06-2.95)*
Rmerge (%)
18.8 (135.6)
CC1/2
0.994 (0.766)
I /σI
20.0 (2.0)
Observations
49009 (4849)
Unique reflections
24916 (2453)
Multiplicity
20.5 (16)
Completeness (%)
100.0 (99.8)
Resolution (Å)
50-2.95 (3.06-2.95)
No. reflections
24916
Refinement
Rwork /Rfree
No. atoms
Protein
Water
Ligands
B-factors
mean
R.m.s. deviations
Bond lengths (Å)
Bond angles (deg)
Ramachandran
Favored (%)
Allowed (%)
Outliers (%)
Clashscore

18.5/21.5
4578
0
0
76.2
0.002
0.52
96.33
3.77
0
3.4

Note. *Values in parentheses are for highest-resolution shell. **Resolution limit used the
criterion of I/σI > 2.0.
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Figure 2-3
X-Ray Structure of Strep-Tagged Apo CasDinG

Note. A. The solved structure of Apo CasDinG is composed of the large RecA body
(light blue), the vestigial FeS domain (dark blue) and the Arch domain (red). B.
Alignment of Apo CasDinG (light blue) to 6FWR E. coli DinG bound to a poly T 12
single stranded DNA substrate (pink), highlights a binding pocket for nucleic acid.
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Figure 2-4
CasDinG Accessory Domain Comparisons

Note. A. Arch domain comparison between ApoCasDinG and E. coli DinG. B. vFeS
CasDinG domain comparison to E. coli DinG FeS domain. C. Zoomed in view of acidic
aspartate glutamate pair in the vFeS which reaches into the nucleic acid binding pocket.
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Figure 2-5
Domain Alignments Comparing PaCasDinG to E. coli DinG.

Note. A. Secondary structure matching of the FeS domains of PaCasDinG to E. coli
DinG. B. DALI alignment of arch domains.
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FeS domains from the two homologs confirm the lack of a coordinated Fe atom in the
CasDinG structure. Examination of the vFeS domain reveals the lack of a loop-helix loop
between alpha helices two an three and the presence of an extended loop between alpha
helices three and four (Figure 2-4, Figure 2-5).
A secondary structure matching alignment of CasDinG to E. coli DinG reveal an
RMSD of 2.93 Å. Further alignment with the solved structure of E. coli DinG bound to
an ADP BeF3 Mg complex, PDB 6FWS, highlights the binding pocket for ATP and
analogs in the CasDinG structure (Figure 2-6). Measurements between the conserved
aspartate residue in the Walker B motif and the magnesium complex show a 6.7Å
distance, whereas the 6FWS structure shows a 4.7Å distance length, indicating that
conformational changes will occur when CasDinG binds an NTP and ssDNA substrate
(the 6FWS structure is E. coli DinG bound to both ssDNA and an ADP complex).

Nucleic acid-binding assays
Knowing that CasDinG contained SF2 helicase motifs and that the structure of
CasDinG highlighted a nucleic acid binding pocket, it was presumed that CasDinG may
bind nucleic acids such as DNA or RNA. CasDinG nucleic acid-binding preferences were
examined using fluorescence anisotropy technology on a Synergy H4 plate reader, and
anisotropy values were analyzed using GraphPad Prism software. The binding constants
were derived using a one-site saturated binding curve and are presented in Table 2-2.
Binding data show that CasDinG can bind both DNA and RNA with apparent affinities of
81 +/- 5.4 nM and 61 +/- 8.1 nM affinities (Table 2-2; Figure 2-6). As these affinities are
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Figure 2-6
Alignment of Apo CasDinG to 6FWS

Note. Image highlights the NTP binding site with the Walker B motifs highlighted in
salmon (CasDinG) and green (6FWS E. coli DinG).
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Table 2-2
Apparent Kd for Nucleic Acid Substrates
Substrate
ssDNA (17 nt.)
ssRNA-PT
ssDNA (17 nt.) ATP
ssDNA (17 nt.) ADP
ssDNA (17 nt.) AMP-PNP

Kd (nM)
81 +/- 5.4
61 +/- 8.1
140 +/- 16
37 +/- 3.2
47 +/- 4.9

within a similar range, we could not determine if there was a true preference for one
nucleic acid substrate over the other. Knowing that ATP binding and hydrolysis can lead
to protein conformational changes, and therefore affinity changes, we hypothesized that
CasDinG affinity for ssDNA may alter in the presence of ATP or analogues. We found
that in the presence of ATP the apparent Kd was 140 +/- 16. This was at most a 2-fold
decrease in affinity. In comparison, the apparent binding affinity of CasDinG for ssDNA
in the presence of the non-hydrolysable analog AMP-PNP was 47 +/- 4.9. Which was
within a 2-fold increase in binding affinities. From this data we concluded that there were
no substantial differences in nucleic acid binding affinities in the presence of analogs
(Figure 2-7).
CasDinG was also able to bind both 17 nucleotide (nt.) and 40 nt. single-stranded
DNA substrates with similar binding affinities, even in the presence of ATP (Figure A-1;
Table 2-1). DinG binding to a blunt-ended duplexed showed no binding in direct
comparison to single-stranded DNA, suggesting that single stranded DNA is required for
loading (Figure A-2).

ATPase Assays
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Figure 2-7
CasDinG Binding to Nucleic Acid Substrates

Note. A. WT CasDinG binding to 5’ FAM labeled 17 nt. Single stranded DNA substrate.
B. WT CasDinG binding to a 5’ FAM labeled 17 nt. single stranded DNA substrate in the
presence of ATP, ADP, or AMP-PNP. C. WT CasDinG binding to a 5’ FAM labeled
phosphorothioated RNA substrate.
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As helicases are defined by their ability to remodel nucleic acid using the
hydrolysis of NTPs, colorimetric malachite green assays were used to measure the
liberation of free phosphate from the provided NTP. SF2 family helicases typically have
nucleic acid stimulated ATPase activity (Christiansen, 2003). Thus, hydrolysis of ATP
was assessed in the presence of single-stranded DNA (ssDNA) and single-stranded RNA
(ssRNA), each substrate forty nucleotides in length. Rates of inorganic phosphate
production were higher for ssDNA than ssRNA, with close to zero rates of hydrolysis
associated with no nucleic acid. DNA substrates of differing lengths were assessed, and
the highest hydrolysis rates were seen for ssDNA (40 nt.), followed by double-stranded
DNA (dsDNA) with a 5’ DNA overhang (34 nt.). Duplexed DNA substrates with a 3’
overhang also showed ATP hydrolysis, but rates were not as high as ssDNA (40 nt.) or
the 5’ overhang duplexed DNA. Blunt dsDNA substrates and ssDNA (17 nt.) showed
rates of ATP hydrolysis equivalent to basal CasDinG (Figure 2-8). This data highlighted
that a nucleic acid substrate needs to be greater in length than 17 nt. to see ATP
hydrolysis.
Helicases can sometimes hydrolyze other NTPs, so we assessed hydrolysis rates
for ATP, UTP, CTP, and GTP in the presence of ssDNA (40 nt.). The highest rates of
NTP hydrolysis were achieved with ATP, with minimal hydrolysis rates for GTP and
UTP. There were no measurable hydrolysis rates for CTP in the conditions tested (Figure
2-7). This data showed that CasDinG will preferentially hydrolyze ATP in the presence
of ssDNA.
To further understand the ATPase activities of CasDinG, Michaelis-Menten
kinetics were performed. Curves assessing ATP hydrolysis rates for CasDinG without

54
Figure 2-8
V0 Plots of ATP Hydrolysis by CasDinG

Note. A. ATP hydrolysis by WT CasDinG is stimulated in the presence of both single
stranded DNA and single stranded phosphorothioated RNA. B. ATP hydrolysis is
stimulated by single stranded nucleic acids with sufficient length. C. WT CasDinG
primarily hydrolyzes ATP. Error bars represent standard deviation from the mean of three
replicates.

55
nucleic acid (basal) pH 6.8, with ssDNA pH 6.8, with ssDNA pH 7.5 and with ssRNA-PT
pH 7.5 were generated (Figure 2-9). Analysis of the Michaelis-Menten CasDinG curves
reveal meager rates of ATP hydrolysis in the absence of nucleic acid at pH 6.8, with a kcat
of 0.28 +/- 0.037 molecules of ATP hydrolyzed per second, whereas in the presence of
ssDNA at pH 6.8, we report a kcat of 11 +/- 0.74 ATP sec-1. At pH 7.5 we saw kcat values
of 32 +/- 0.99 ATP sec-1 with ssDNA and 23 +/- 0.71 ATP sec-1 for ssRNA-PT (Table 23). This data showed that a pH shift from 6.8 -7.5 resulted in a 2.9-fold difference in the
turnover number of ATP hydrolysis when CasDinG is in the presence of both ATP and
ssDNA (Table 2-3).

Table 2-3
Michaelis-Menten Kinetic Parameters for ATP hydrolysis
[nucleic
acid]
nM

pH

500 nM

0 nM

6.8

18.5 nM

150 nM

6.8

10 nM

100 nM

7.5

20 nM

200 nM

7.5

[CasDinG]
Substrate
nM
Basal
ssDNA
(40 nt.)
ssDNA
(40 nt.)
ssRNA-PT
(17 nt.)

Vmax (µM sec1
)
0.14 +/0.019
0.20 +/0.014
0.32 +/0.0099
0.46 +/0.014

Km (µM)

kcat (ATP sec-1)

2.0 x102 +/- 77

0.28 +/- 0.037

80 +/- 24

11 +/- 0.74

160 +/- 15

32 +/- 0.99

180 +/- 17

23 +/- 0.71

The differences between ssDNA and ssRNA-PT at pH 7.5 are within one order of
magnitude of each other. E. coli DinG has been reported to hydrolyze 1.59 molecules of
ATP sec-1 without nucleic acid and 24.1 molecules of ATP sec-1 in the presence of
ssDNA (Voloshin et al., 2003).
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Figure 2-9
Michaelis-Menten Curves of ATP Hydrolysis by CasDinG

Note. A. Rates of ATP hydrolysis at various ATP concentrations using 500 nM WT
CasDinG with no nucleic acid substrates, pH 6.8. B. Rates of ATP hydrolysis at various
ATP concentrations using WT CasDinG and a 40-nucleotide single stranded DNA
substrate at pH 6.8 C. Rates of ATP hydrolysis at various ATP concentrations using WT
CasDinG and a 40-nucleotide single stranded DNA substrate at pH 7.5 D. Rates of ATP
hydrolysis at various ATP concentrations using WT CasDinG and phosphorothioated
single stranded RNA substrate at pH 7.5.
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Therefore, we concluded from these Michaelis-Menten curves that CasDinG
ATPase rates were within a similar range as that of Non-Cas DinG enzymes. To make
accurate comparisons between all curves reported here, we would need to repeat the
experiments in same buffers/pHs for each substrate or lack thereof. To determine whether
the phosphorothioated RNA backbone impacts ATPase rates, another curve will need to
be generated with a native RNA backbone in RNAse-free conditions.

Helicase assays
Non-Cas DinG enzymes if they are helicases, have 5’-3’ polarity, suggesting that
this enzyme might be the same given its ability to bind nucleic acid and hydrolyze ATP
in the presence of both RNA and DNA (Voloshin et al., 2003; Thakur et al., 2014). Here
we investigated the substrate preferences of CasDinG for different DNA and RNA
duplexes with 5’ and 3’ overhangs (Figure A-4). CasDinG was first assessed for helicase
activity against 5’ FAM-labeled DNA duplexes with either a 5’ overhang, a 3’ overhang,
or a blunt end (Figure 2-10). Out of these substrates, CasDinG only unwound the 5’
overhang dsDNA substrate. This is the first data showing a CRISPR associated helicase
to have 5’-3’ polarity. Given that DinG homologs can unwind RNA/DNA hybrids, we
next investigated whether CasDinG would be able to unwind 5’ FAM-labeled DNA/RNA
hybrids and RNA duplexes (Figure 2-10) (Voloshin & Camerini-Otero, 2007). CasDinG
was found capable of unwinding a 5’ overhang duplexed-hybrid only when the overhang
was single-stranded DNA. There was no unwinding observed for a duplexed RNA
substrate or for a hybrid duplex in which the overhang was single-stranded RNA.
The no ATP control on the native PAGE gels shows a small amount of intensity
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associated with a single-stranded band, suggesting that the initial binding of CasDinG to
duplex with single-stranded overhang(s) results in some displacement of duplex due to
thermal fraying. However, direct comparison of the ATP-containing reactions shows a
clear and consistent increase in substrate displacement, consistent with CasDinG being a
5’-3’ ATP-dependent helicase (Figure 2-10).
Time trial comparisons of 5’ FAM-labeled nucleic acid substrates with 25 nM
protein concentrations show that active helicase substrates are more than 70% unwound
within the first 60 seconds of the reaction. The highest percentages of unwound duplex
were found with the 5’ DNA overhang hybrid duplex, indicating there may be a
preference for hybrid duplexes, however given that helicases can perform annealing
reactions as well as unwinding reactions, rates of unwinding would have to be determined
at multiple protein concentrations to determine true nucleic acid unwinding preferences.
To further assess whether duplex displacement was dependent upon the
hydrolysis of ATP, CasDinG was assayed for helicase activity with a 5’ FAM labeled
5’ overhang duplexed DNA substrate in the presence of ATP, ADP, AMP-PNP, or
ATPγS. It was only in the presence of ATP that substantial unwinding of duplex
substrates was observed, indicating that hydrolysis of ATP is essential for proper helicase
function (Figure 2-11).
Non-Cas DinG enzymes, such as E. coli DinG, rely upon divalent metals to
unwind duplexed nucleic acids (Voloshin et al., 2003). Divalent metals can be used to
coordinate the phosphate backbone of ATP and nucleic acid substrates. Here we
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Figure 2-10
CasDinG is a 5’- 3’ ATP-Dependent Helicase

Note. A. Native PAGE analysis of DNA helicase substrates. B. Native PAGE analysis of
RNA and DNA hybrid helicase substrates. C. Graph displaying the percent of helicase
substrate unwound as a function of time. Error bars represent standard deviation from the
mean of three replicates.
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Figure 2-11
Unwinding is Stimulated by ATP and Divalent Ions

Note. A. Native PAGE showing that unwinding of a duplexed DNA substrate is
dependent upon ATP hydrolysis. B. Bar graph depicting the % of duplexed DNA
substrate unwound in the presence of ATP analogues. Error bars represent standard
deviation from the mean of three replicates with the no ATP control acting as the control
for 0% unwound. C. Native PAGE showing unwinding of duplexed DNA substrate in the
presence of various divalent ions.
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investigated the divalent metal requirements for CasDinG in the presence of a 5’ FAMlabeled 5’ overhang DNA duplex (Figure 2-11). Data show that CasDinG can displace
DNA in the presence of Mg2+, Mn2+, Ca2+, Ni2+, and Co2+ but not Zn2+ or Cu2+.

Mutational Analysis
CasDinG mutants were initially generated to determine whether DNAse/RNAse
activity visualized on helicase assays was due to CasDinG or contaminating nucleases
(nuclease data not shown). These mutations were made using a structural model
generated by the Robetta server (Figure A-7). Although the nuclease data did not result in
a successful avenue of study, we utilized these mutations to understand the function of
accessory domains.
The Walker B motif, DEAH, located at position 337, was mutated to AAAH. The
∆N-terminus truncation eliminated the amino acids 18-128 and included deletion of the Q
motif. The ∆Arch (350-469) and ∆vFeS (195-287) with a x5 glycine linker, were domain
knockouts generated at the junction between the specified domain and Domain1 of the
RecA core (Figure 2-12). All mutants were assayed for their ability to unwind a 5’ FAMlabeled DNA with a 5’ overhang. ∆Arch and ∆DEAH both abolished DNA unwinding
activity, whereas ∆N-terminus truncation and ∆vFeS showed appreciable amounts of
displaced nucleic acid (Figure 2-12). However, it should be mentioned, that the ∆N.
terminus truncation helicase activity has not been consistent. Alternative protein
preparations have resulted in no duplex unwinding. Whether this is due to protein
preparation errors, or other human errors has yet to be elucidated but could be remedied
through more biological replicates deciphering ∆N-terminus truncation function.
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Next the ∆DEAH, ∆N-terminal truncation and ∆Arch were assessed for their
ability to bind ssDNA (17 nt.). All mutants tested maintained the ability to bind and had
similar binding affinities ranging from 42 - 94 nM (Figure A-2; Table A-1). There were
not sufficient concentrations of the ∆vFeS to assess binding affinities. Next rates of ATP
hydrolysis were assessed for all four mutants in the presence of ssDNA (40 nt.). ∆Arch
and ∆N-terminus truncation maintained similar rates of ATP hydrolysis to WT, whereas
∆vFeS and ∆DEAH resulted in diminished ATP hydrolysis (Figure 2-12). Given that the
∆vFeS mutant showed helicase activity in a 20-minute reaction and little to no ATPase
activity in a 3 minute reaction, it is hypothesized that the ∆vFeS is capable of minimal
rates of ATP hydrolysis needed to unwind duplexes. To fully understand the mechanism
of ATP hydrolysis, Michaelis-Menten kinetics should be performed using the ∆vFeS
construct.
To ensure that the removal of domains did not disrupt the folding of CasDinG, far
UV circular dichroism was used to assess the structural integrity of purified proteins. This
data was collected for WT CasDinG, ∆DEAH, and ∆N-terminal truncation. ∆Arch and
∆vFeS have not had CD data collected as protein concentrations were too low for the
volumes needed to assay. Analysis of the CD data shows that the protein is mostly alphahelical, and a comparison of the mutants with WT shows no substantial loss of structural
integrity when purifying these mutants (Figure A-3).
Comparison of the x-ray crystal generated model and the predicted model, along
with increased knowledge of helicase motifs, revealed that the initial mutants may have
been overly harsh in their construction, meaning that more of a domain was deleted than
necessary. New mutants utilizing the x-ray crystal structure as a reference with fewer
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Figure 2-12
Functional Analysis of CasDinG Domains via Mutagenesis

Note. A. Gene schematics comparing WT CasDinG to each of the studied mutants. B.
Rates of ATP hydrolysis by CasDinG and mutants as measured by concentration of
inorganic phosphate as a function of time. C. Native PAGE analysis of a duplexed DNA
helicase substrate in the presence of CasDinG (mutants) and ATP. D. Bar graph analysis
of % duplexed DNA unwound as a function of CasDinG construct. Error bars represent
standard deviation from the mean of three replicates.
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amino acid deletions, may be more accurate in determining the function of accessory
domains in CasDinG function.

In Vivo Plasmid Curing Assay
Previous research by Dr. Crowley showed that all type IV CRISPR-Cas genes are
necessary for type IV-A system targeting, including the dinG-like gene (Crowley et al.,
2019). Using a similar plasmid curing assay, we assessed the necessity of the accessory
domains (∆Arch, ∆N. terminal truncation, and ∆vFeS) for type IV-A immune system
function (Figure 2-13). All four mutants (∆DEAH_AAAH, ∆N-terminal truncation,
∆Arch, and ∆vFeS) inhibited the targeting ability of the type IV-A system in
vivo. Although noticeably, there is variability in the ratio of target to non-target colonies
in both the ∆N-terminal truncation and ∆vFeS data sets. Additional biological replicates
could allow for greater understanding of whether the data skews closer towards a
knockout of immune system function or not. However, in comparison to the WT positive
control, all mutants did not provide proper type IV CRISPR immune system function.

Type IV-A Complex and CasDinG
Protein expression conditions were identified which allowed for a high yield of
type IV-A RNP complex to be purified. Furthermore, conditions were identified that
allowed for the co-expression and co-purification of CasDinG with the type IV-A RNP
complex (Figure 2-14). Protein purification occurred over two affinity columns (nickel &
streptavidin) followed by size exclusion. Affinity tags were placed on Csf1 and Csf2 with
no tags on the CasDinG. SDS-PAGE after the affinity columns showed that CasDinG
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Figure 2-13
In Vivo Plasmid Curing Assay.

Note. A. Schematic of the protocol used to count colonies for the in vivo plasmid curing
assay. B. Bar graph showing the ratio of target/non target plasmid containing cells on the
y axis as a function of CasDinG construct used in the assay, in addition to the rest of the
type IV-A immune system. A ratio of ~1 or higher implies a dysfunctional immune
system.
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Figure 2-14
Type IV-A Protein Purification

Note. A. Size exclusion chromatogram of the Type IV-A RNP complex eluting off a
Superdex 200 Increase 10/300 GL column. B. SDS PAGE of recombinantly expressed
and purified Type IV-A ribonucleoprotein complex (Csf2, Csf5/Cas6, Csf1, and Csf3). C.
Size exclusion chromatogram of the Type IV-A RNP + CasDinG complex eluting off a
Superdex 200 Increase 10/300 GL column. D. SDS PAGE of recombinantly expressed
and purified Type IV-A ribonucleoprotein complex and CasDinG stained with Coomassie
blue.
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was copurifying with the complex. However, size exclusion chromatography shows that
CasDinG copurifies with the type IV-A RNP complex in a later elution than the type IVA RNP complex without CasDinG, indicating that CasDinG does not form a stable
interaction with the complex. If a stable interaction had formed, we would have expected
that the CasDinG + RNP complex would have resulted in complex that eluted prior to
RNP complex alone.
Additionally, the estimated molecular weights for type IV-A RNP complex
resemble a 1:5-6:1:1 ratio rather than the previously described 1:2:1:1 ratio of
Csf1:Csf2:Csf3:Csf5/Cas6, respectively (Taylor, 2021). Later elutions are associated with
smaller molecules, leading to the hypothesis that the interaction between CasDinG and
type IV-A RNP complex is transient, dependent upon nucleic acid substrates, or a result
of column preferences. It is unknown what the conditions for the interaction are.
Knowing that the type IV-A CRISPR-cas system can target plasmids in vivo led
to the development of in vitro binding assays using fluorescence anisotropy. There is
currently no peer-reviewed published work reporting in vitro binding affinities for type
IV-A RNP complexes to nucleic acid substrates. The type IV-A RNP complex was
assessed for binding affinities to single-stranded DNA targets with differing PAM
sequences (Figure 2-15). The estimated Kd values for these substrates were all below 10
nM, suggesting high affinities between the complex and target substrates (Table 2-4).
This data indicated that all three PAMs would be suitable for use in in vitro
studies. The type IV-A RNP complex that had been co-expressed with CasDinG was
assayed for single-stranded DNA (TTTC PAM sequence) binding once. This data showed
a preliminary Kd of 5.523 nM, suggesting that CasDinG does not interfere with RNP
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Table 2-4
Apparent Kd of ssDNA Alternative PAM Substrates
Substrate

Kd (nM)

ssDNA Target GGAAA

9.3 +/- 0.81

ssDNA Target GCGAT

9.0 +/- 1.4

ssDNA Target AAAAA

8.4 +/- 1.3

complex binding target sequences (Figure A-6).
Current literature suggests that type IV-A systems can reduce gene expression
without DNAse activity (Guo et al., 2022), however in vitro plasmid cleavage data shows
that non-target and target-containing plasmids can be nicked in the presence of the type
IV-A complex (Figure 2-15). The nicking occurs whether CasDinG is present or not. To
understand whether this nicking activity is real or due to contaminating nucleases, point
mutations eliminating this activity are necessary. If nicking occurs, it could allow for
CasDinG to load on an open ssDNA end.
It should be noted that all fluorescence anisotropy reactions with estimated Kd
values below 100 nM should be viewed cautiously, as substrate concentrations of nucleic
acid were held constant at 10 nM. Therefore, we can only reasonably state that nM
binding is occurring with these substrates. The probe's concentration should be at least
nine times lower than the estimated Kd to obtain accurate values using the traditional fit
of % bound = [S]/([S] + Kd). With the values generated here, pico or femto molar probe
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Figure 2-15
Type IV-A Preliminary Binding and Cleavage Data

Note. A. Binding of Type IV-A RNP complex to single stranded nucleic acid sequences
with alternative PAM sequences. Measured using fluorescence anisotropy. B. Agarose
gel showing cleavage a GGAAA PAM containing plasmid.
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levels would be needed for accurate Kd estimation. Data collected with FAM-labeled
substrates at those lower concentrations suffers from higher background noise. Thus, an
alternative method of labeling substrates, such as radiolabeling may be helpful.

Discussion
The role of the dinG-like gene associated with type IV-A CRISPR-Cas systems
was unknown prior to the work performed in this thesis. The biochemical
characterizations performed on CasDinG establish this enzyme as a 5’-3’ ATP-dependent
helicase with an essential role in the in vivo function of the type IV-A CRISPR-Cas
system from Pseudomonas aeruginosa strain 83. Initial binding assessments revealed a
preference for single-stranded nucleic acid substrates. Furthermore, it was shown that
single-stranded nucleic acid was required for binding to duplexed substrates as there was
no binding to a blunt duplexed nucleic acid substrate. Binding affinities for ssRNA were
within the same range as ssDNA. From this we can infer that there is no substantial
affinity difference between the two substrates. It is known that helicases can translocate
along nucleic acid by changing the affinity of one nucleic acid-binding domain from
another by utilizing ATP hydrolysis (Pyle, 2008; Cheng & Wigley, 2018). Assessment of
binding affinities of ssDNA in the presence of ATP analogs did not show data indicative
of higher or lower binding affinities. It may be that the use of fluorescence anisotropy to
measure binding affinities is not sensitive enough to detect the changes in domain affinity
for nucleic acid in the presence of ATP with single-stranded DNA.
Subsequent analysis of the NTPase activities of CasDinG suggests that ATP is the
preferred NTP substrate in the conditions tested. ATPase velocity plots showed higher
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rates of ATP hydrolysis using ssDNA (40 nt.) over ssRNA substrates (40 nt.).
Interestingly no ATP hydrolysis was visualized for a ssDNA (17 nt.) which CasDinG was
shown to bind. This data shows that there is a required nucleic acid substrate length for
ATP hydrolysis. The lack of ATP hydrolysis in the presence of ssDNA (17 nt.) could be
the reason why there were no discernable binding differences of ssDNA (17 nt.) in the
presence of ATP analogues. However, this does not explain the lack of binding affinity
differences between ssDNA (40 nt.) in and out of the presence of ATP. The binding data
combined with ATPase data suggest that CasDinG surveys its environment for singlestranded nucleic acids on which it can bind. Following nucleic acid binding, CasDinG
may then translocate on ssDNA. As no helicase activity was visualized for RNA
overhang substrates, the ATP hydrolysis rates differences seen between CasDinG bound
to DNA versus RNA-PT may be due to either functional activity differences or
limitations imposed by the phosphorothioated backbone of the RNA substrate. It should
be noted that helicase assays did not use RNA-PT.
Helicase data showed unwinding of duplexed nucleic acid with a 5’ overhang and
little to no displacement of 3’ overhang substrates. This data shows that CasDinG has a
preferred polarity of 5’-3’ which differs from that of Cas3 (3’-5’), the only other CRISPR
associated helicase to be characterized thus far (Sinkunas et al., 2011). CasDinG does not
bind and cannot unwind blunt dsDNA duplexes suggesting that a single-stranded nucleic
acid is required for loading CasDinG onto a given substrate. Furthermore, substantial
displacement of the labeled strand is dependent upon the presence of ATP and a forked
substrate is not required to see displacement. Furthermore, RNA-containing substrates
did not show unwinding when the loading strand was RNA, despite data that shows
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CasDinG binding ssRNA-PT and hydrolyzing ATP in the presence of ssRNA-PT. This
result could be due to the A-form nature of RNA and may coincide with the lower rates
of ATP hydrolysis seen with CasDinG in the presence of ssRNA-PT. CasDinG could
perhaps displace transcription machinery which would support the hypothesis presented
by the Guo group, who show that type IV-A systems can inhibit gene expression without
cleavage of the gene (Guo et al., 2022). However, experiments showing the ability of
CasDinG to displace proteins are still needed. Helicase assays showed duplex unwinding
dependence on divalent ions. CasDinG was able to unwind duplexed DNA in the
presence of Mg2+, Mn2+, Ca2+, and Ni2+ but not Cu2+ or Zn2+.
This thesis presents the first crystal structure of a CRISPR-associated DinG
helicase. The 2.95 Å structure of CasDinG reveals a model that maintains a core
composed of two RecA domains with two accessory domains inserted into the RecA1
lobe. The vFeS domain appears as an accessory to the RecA domain, branching off the
RecA1 lobe, and does not contain any density indicative of bound metal ions. The vFeS
domain adopts a closed alpha-helical domain held close to the RecA body beneath the
arch domain. One of the alpha-helices in the vFeS domain is near the binding pocket for
nucleic acid with an aspartate glutamate pair at positions 271 and 272. These residues
may play a role in coordinating metal ions, but that has yet to be studied. When CasDinG
is aligned with the polyT substrate from the 6FWR E. coli DinG structure, we see that the
entire vFeS domain clashes with the ssDNA substrate, indicating that domain
rearrangements may occur upon binding nucleic acid substrates.
Interestingly, deletion of the vFeS domain resulted in reduced rates of ATP
hydrolysis and a non-targeting type IV-A system in vivo, suggesting a structural role in
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forming an ATP binding/hydrolysis pocket. Deletion of the vFeS domain did not abolish
DNA duplex unwinding, suggesting that ATP hydrolysis still occurs at a lower rate than
WT. Alternatively, the vFeS domain deletion construct could adopt a conformation
adapted to displacing or kinking nucleic acid duplexes. This data set is significant, as
non-CasDinG homologs require the presence of a FeS cluster to unwind duplexed nucleic
acid, whereas we see that CasDinG does not require a FeS cluster nor even the vFeS
domain to unwind duplexes. Although we know that unwinding still occurs, we do not
know whether the rates of unwinding are altered. It would be prudent to determine kunwind
for domain mutants in future studies and confirm results with biological replicates.
The arch domain appears as a second insert in the RecA1 lobe. Deletion of the
arch domain results in an enzyme incapable of unwinding duplexed nucleic but capable
of binding ssDNA and hydrolyzing ATP. This data suggests that the arch may play a role
in strand separation. The N-terminus was not observed in the electron density, and there
is no structural data on which to comment. However, the Alphafold structure prediction
showed that there are structured alpha helical regions and unstructured loops in the Nterminus. The absence of the N-terminus in the x-ray structure suggests that perhaps the
N-terminus is flexible. The N-terminus may play a role in CasDinG immune function as
deletion results in a dysfunctional type IV-A immune system incapable of targeting
plasmid, however given that the Q motif is removed with this mutation, lack of targeting
should have been anticipated. Further experimentation using an N-terminal truncation
that does not remove the Q motif should be pursued. Arch domains in other SF2 family
proteins may function as interaction sites for other proteins, suggesting that this may be a
site of interaction between CasDinG and the type IV-A complex; this is an avenue of
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research for future studies (Abdulrahman et al., 2013). Additionally, future structures of
CasDinG bound to DNA substrates and ATP analogs will provide further insight into the
accessory domains' structural, functional and regulatory roles.
Early experiments conducted by Dr. Val Crowley revealed that a WT DEAH
motif is essential for the targeting ability of the type IV-A system in vivo. This thesis' in
vivo analysis of domain mutations suggests that a CasDinG enzyme with both ATPase
and helicase activity is essential for proper CRISPR system function. These findings are
significant because we have determined a biochemical mechanism for a type IV system
protein directly involved in CRISPR plasmid interference. This allows us to make an
educated hypothesis on the interference mechanisms utilized by these systems.
SDS-PAGE gels show that CasDinG and the type IV-A RNP complex co-purify
over a size exclusion column, suggesting that there may be interactions mediated by
nucleic acid, between CasDinG and complex. The size exclusion chromatogram showed
RNP complexes with CasDinG eluting at later elution volumes than isolated type IV-A
RNP. This data was not anticipated as size exclusion columns work by sorting larger or
higher molecular weight molecules from smaller ones. We would have expected that a
stable CasDinG-type IV-A RNP complex would have eluted at a volume expected for a
complex of 255 kDa, assuming a 1:2:1:1 ratio of RNP complex proteins (Taylor, 2021).
Instead, we observe an RNP complex eluting at a volume equivalent to a complex of 297
kDa. This size of complex indicates an alternative ratio of RNP enzymes closer to 1:56:1:1 (Csf1:Csf2:Csf3:Csf5/Cas6). The CasDinG-type IV RNP complex eluted at a
volume equivalent to a complex of 185 kDa, significantly less than the predicted 255
kDa, suggesting that the interaction between CasDinG and RNP may be transient or be
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dependent on the binding of nucleic acid substrates. More studies evaluating the
relationship between CasDinG and RNP complex are needed before definitive statements
are made regarding RNP complex composition.
Fluorescence anisotropy binding assays revealed that the type IV-A RNP complex
binds at least three ssDNA PAM sequences with nM affinity. Binding assays also showed
that the CasDinG + type IV-A RNP complex binds ssDNA with similar affinities to RNP
complex alone. Knowing that CasDinG is a helicase, it would be prudent to evaluate the
CasDinG + type IV-A complex affinity for duplexed nucleic acid and the type IV-A RNP
complex (297 kDa) affinity for duplexed nucleic acids. This information would be
helpful for understanding when and if CasDinG is for type IV-A complex binding.
CasDinG may be necessary during RNP complex formation and interference of MGE.
Preliminary plasmid cleavage data indicates that small amounts of nickase activity may
be associated with the RNP complex. The single-stranded DNA breaks resulting from
nickase activity could provide a loading zone for CasDinG.
Chapter 2 of this thesis reveals a hypothetical model in which CasDinG could
promote alternative RNP complex compositions and act as a 5’-3’ helicase that runs on
DNA, knocking off RNA transcripts (Figure 2-16). Alternatively, CasDinG could
displace transcription machinery, thus blocking transcription of RNA and thereby
inhibiting translation. Whether CasDinG can displace the type IV-A RNP complex when
bound to a target sequence should be assessed in the future using translocase assays.
Future work on type IV systems will require in-depth knowledge of CasDinG
functionality and a more in-depth analysis of RNP complex composition. Functional
knowledge of a type IV-A helicase mechanism provides powerful insight into the breadth
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Figure 2-16
Hypothesized Role of CasDinG in CRISPR System Function
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and depth of microbial immune systems and enhances our understanding of the versatility
of SF2 helicases. As helicases are utilized in nearly every facet of nucleic acid biology,
the continued study of CasDinG and the type IV-A RNP complex could result in a new
tool to be used in gene therapeutics by acting as a gene expression regulator.
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CHAPTER 3
IN VITRO CHARACTERIZATIONS OF BACTERIAL IMMUNE SYSTEM
PROTEINS CAS12A2 AND JETB

Abstract
Sulfuricurvum sp. PC08-66 encodes a type V-A2 CRISPR-Cas system that
consists of a cas12a2 gene and a CRISPR array to protect against invasive nucleic acids.
Phylogenetic analysis shows that type V-A2 Cas12a2 is distinct from Cas12a, a DNAspecific reprogrammable nuclease. Cas12a2 proteins consistently have a lower molecular
weight than Cas12a, contain a domain foreign to Cas12a, maintain RuvC nuclease motifs,
and are sometimes found adjacent to cas12a genes. These distinctions suggest that
Cas12a2 may play a unique role in type V immunity. This thesis contains biochemical
and structural analyses that aid in understanding Cas12a2 function. Pre-crRNA
processing assays monitored the cleavage of RNA in the presence of SuCas12a, an
essential step in CRISPR immune activity. DNA binding and cleavage assays monitored
nuclease activity. Circular dichroism verified the structural integrity of mutants, and a
preliminary low-resolution structure of SuCas12a2 bound to a guide RNA was
determined using cryo-electron microscopy. Wadjet is a novel immune system that
inhibits plasmid transformation efficiencies in B. subtilis. To better understand this
system, this thesis contains methods to recombinantly express and purify JetB and
circular dichroism data to verify structural integrity.
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Introduction

Type V CRISPR-Cas Systems
Type V systems are Class 2 CRISPR-Cas systems comprised of single proteins
which complex with guide RNA (Koonin & Makarova, 2017). These systems have been
used in genome editing applications as they only require a single gRNA, can process their
pre-crRNA into a gRNA, and contain a single RuvC nuclease domain (Shmakov et al.,
2017; Świat et al., 2017; Alok et al., 2020). The most studied of the Type V enzymes,
Cas12a, comes from the type V-A subtype and uses a single RNA guide to cleave doublestrand DNA, resulting in a cut with staggered sticky ends (Zetsche et al., 2015).
Bioinformatic studies surrounding Cas12a led to the discovery of Cas12a variant
nucleases termed Cas12a2. These Cas12a2 genes are sometimes directly adjacent to
Cas12a genes and share the same CRISPR array (Begemann et al., 2017). These genes
can differ in length and domain organization from Cas12a, suggesting a difference in
function (Figure 3-1). In particular, the Cas12a2 genes possess a novel domain of
unknown function between RuvC motifs 1 and 2 and lack the Nuc domain housed by
Cas12a.
Cas12a2 variants were shown to edit the genome of Oryza sativa, producing
insertion-deletion events in targeted genes, suggesting that Cas12a2 targets dsDNA,
similar to Cas12a (Begemann et al., 2017). However, the mechanism and structure of the
Cas12a2 variants remain unknown and provide an opportunity to discover novel genomeediting tools.
In this thesis, PAGE analysis shows that SuCas12a2 processes a long pre-crRNA
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Figure 3-1
Organization of Type V-A2 Systems

Note. A. Organization of type V-A2 CRISPR systems in the Jackson lab. Cas12a is
colored gold and Cas12a2 is colored pink. B. Protein comparison of type V-A2
SuCas12a2 in comparison to type V-A LbCas12a. The RuvC nuclease motifs and notable
domains and structural features are labeled. Figure adapted from Begemann et al. 2017
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into gRNA, binds single-stranded and double-stranded DNA with a TTTC PAM and may
possess DNAse activity. Cryo-electron microscopy shows a substantial conformational
shift upon binding gRNA. This work is significant as this was the first time bioprocessing
was shown for the Cas12a2 variant proteins and the amino acid residues essential for
RNA processing were identified. This provided a foundation for the discovery of the
interference mechanism by the Jackson and Biesel labs (Dymetrenko et al., 2022).
Overall, this work has allowed for the characterization of a microbial protein which can
be repurposed for use as a biotechnology tool as it’s requirements for nucleic acid
targeting differ from other type V proteins.

Wadjet Defense System
Bioinformatic searches using genome databases in combination with secondary
structure predictions using the PHYRE server identified a putative immune system called
Wadjet, near known defense genes in defense islands (Doron et al., 2018). Wadjet
systems are a four-gene system composed of jetABCD, however there are systems which
contain only the jetABC genes. Homology searches suggest that these genes are distantly
related to condensin systems such as the MukBEF condensin complex from E. coli
(Doron et al., 2018). MukBEF complexes form protein rings composed of homo and
heterodimeric complexes and are critical for segregating genomic material during cell
replication (Rybenkov et al., 2014). HHPRED analysis of Pfams contained by these
proteins indicate that jetC houses an ATPase domain and jetD shares similarities with
topoisomerase IV (Doron et al.; 2018). Recent work has shown that these systems
reduced the transformation efficiency of the plasmid pHCMC05 in B. Subtilis (Doron et
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al., 2018). However, how these systems interact with plasmids or other nucleic acids,
such as ssDNA phage, are unknown. Knowing that all cells require genomic segregation
and compaction, both biochemical and structural characterization of these systems is
needed. By studying a putative condensin system, we stand to learn more about genetic
compaction and segregation methods that could alter transfection or transformation rates
of nucleic acid into various cell types.
Wadjet systems may form protein complexes capable of binding nucleic acid,
like distantly related condensin systems, and may loop DNA or supercoil DNA to disrupt
the ability of foreign plasmids to segregate correctly during cellular replication. This
thesis provides the framework for studying Wadjet systems from Azotobacter vinelandii
DJ and Mycobacterium MCS. Alphafold prediction models of A. vinelandii jet genes in
tandem with DALI server searches support the findings by Doron and show that Jet
proteins share structural similarities to condensin systems, such as structural maintenance
of chromosome proteins. However, all DALI server matches show less than 20%
similarity (Figure 3-2; Figure B-3) (Holm, 2022; Mirdita et al., 2022). It is interesting to
note that the Wadjet systems from both A. vinelandii DJ and Mycobacterium MCS. do
not contain a jetD gene, suggesting that either these systems contain non-functional
immune systems or recruit endogenous proteins.
With the genes from these systems transplanted to recombinant expression
vectors, one can take steps towards identifying this novel condensin-interference system's
structure and determine the biochemical methods it employs to limit plasmid replication.
This thesis provides the first biochemical data showing that AvJetB purifies as a dimer
and maintains its structural integrity throughout the purification process. This work lays
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Figure 3-2
Azotobacter vinelandii Wadjet Overview

Note. A. Schematic of the Wadjet defense system, highlighting proximity of jet genes to
transposase genes. B. Alphafold generated models of Wadjet proteins (JetA, JetB, and
JetC) alongside a theoretical condensin complex model. The theoretical condensin
complex model was Adapted from “DNA looping in Transcriptional Regulation”, by
BioRender.com (2020). Retrieved from https://app.biorender.com/biorender-templates.
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the foundation for the future expression and purification of other Wadjet genes which
allow for in depth biochemical characterization of Wadjet complexes. Overall, the study
of nucleic acid condensin complexes will provide enhanced understanding of chromatin
compaction and its effects on transcription and translation as well as an enhanced
understanding of plasmid sharing within microbial communities.

Methods

Nucleic Acid Substrate Preparation
IDT and Eurofins synthesized nucleic acids. Nucleic acids, if labeled in-house,
were labeled with a fluorescein label on the 5' end or were radiolabeled on the 5' end with
(γ-32P) -ATP (Perkin Elmer) and T4 polynucleotide kinase (NEB). Radiolabeled nucleic
acids were separated from excess 32P ATP with a MicroSpin G-25 column (GE
Healthcare).
Single-stranded nucleic acids were then gel purified using 12% 7 M UREA PAGE
gels, gel extracted, ethanol precipitated, and then reconstituted in water. Duplexed
nucleic acids were generated by adding complementary oligonucleotides in an equimolar
ratio in the presence of NEB buffer 2.1 and heated to 95°C. These oligonucleotides were
slowly cooled to room temperature before running on 12-15% native PAGE gels. Duplex
bands were then gel extracted, ethanol precipitated, and reconstituted in water.

Cloning of Cas12a2
SmCas12a2 was obtained from Benson Hill Biosystems and was codon-optimized
for plant cell lines. SmCas12a2 mutants were created using the Q5 Site-Directed
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Mutagenesis kit (New England BioLabs (NEB)). The N-terminal HIS tagged SuCas12a2
gene was obtained from Benson Hill Biosystems in a plant codon-optimized pet vector
containing the CRISPR array that codes for a guide RNA. SuCas12a2 mutants were
generated using the Q5 Site-Directed Mutagenesis kit (NEB). See Table B-3 for a list of
primers and Table B-4 for constructs generated.

Protein Expression & Purification

SmCas12a2 Expression & Purification
The cloned vector containing the SmCas12a2 gene was transformed into
Escherichia coli BL21 (DE3) chemically competent cells (Novagen). From the
transformation plate, a colony was picked and placed into an overnight outgrowth with
0.1 mg/ml ampicillin. 500 mL of Luria-Bertani medium in a 2.8 L flask is inoculated with
a 5 mL overnight starter. Cells are grown to an optical density between 0.4-.05 OD600 at
30°C 200 RPM in a shaking incubator. When OD600 is reached, the cells were induced
with 0.05 mM IPTG, and the temperature was dropped to 12°C for 16 hours. The cells
were then harvested via high-speed centrifugation and stored at -80°C. All mutants were
expressed in the same manner.
Cells were homogenized on ice with 8 mL/gram lysis buffer (25 mM NaPO4 pH
7.4, 0.5 M NaCl, 10 % glycerol, 2 mM MgCl2, 20 mM imidazole, 5 mM Tris [2carboxyethyl] phosphine hydrochloride (TCEP), 0.1 % TWEEN 20). The protease
inhibitors 1000 x Aprotinin (0.5mg/mL), 1000 x Leupeptin (0.5 mg/mL), 1000 x
Pepstatin A (0.7 mg/mL), & 150x phenylmethylsulphonyl fluoride (PMSF) (25 mg/mL)
and 0.25 mg/mL lysozyme were added prior to cell lysis. Cells were incubated on ice for
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20 minutes. Probe sonication for cell lysis was performed at settings of 5/50. The lysate
was then clarified by high-speed centrifugation at 15 K RPM for 15 minutes.
All purification steps were performed at 4°C. The supernatant was loaded onto a
nickel affinity column (Nickel His trap FF crude, GE Healthcare) that had been preequilibrated with lysis buffer. The column was washed with lysis buffer and then eluted
with elution buffer (25 mM NaPO4 pH 7.4, 0.5 M NaCl, 10 % glycerol, 2 mM MgCl2,
500 mM imidazole, 5 mM TCEP, 0.1 % TWEEN 20). Fractions with SmCas12a2 were
pooled. Protein was loaded onto a desalting column (HiPrep 26/10 Desalting, GE
Healthcare) that had been pre-equilibrated into a low salt buffer (25 mM NaPO4 pH 7.4,
50 mM NaCl. 10 % glycerol, 2 mM MgCl2, 5 mM TCEP, 0.1% TWEEN 20), and then
SmCas12a2 fractions were run over the column. Protein elution was collected and then
run over an IEX column (HiTrap SP HP cation exchange, GE Healthcare). The column
was washed with low salt buffer. The protein was eluted into a high salt buffer (25 mM
NaPO4 pH 7.4, 1 M NaCl, 10% glycerol, 2 mM MgCl2, and 5 mM TCEP, 0.1% TWEEN
20. Samples were spun down using a spin concentrator (Corning® Spin-X® UF 100
MWCO) for placement on a size exclusion column (HiLoad 26/600 Superdex 200 pg.,
GE Healthcare). Protein was eluted into a final buffer (25 mM HEPES pH 7.4, 100 mM
NaCl, 2 mM MgCl2, 1 mM DTT, 10% glycerol). Protein samples were concentrated and
stored at 4°C.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), and the appropriate extinction coefficient was applied (Table B-1).

ApoSuCas12a2 Expression and Purification
The Sulfuricurvum sp. PC08-66 cas12a2 gene was obtained from Benson Hill
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Biosystems in a plant codon-optimized pet vector with an N-terminal HIS tag.
SuCas12a2 mutants were created using the Q5 Site-Directed Mutagenesis kit (New
England BioLabs (NEB)).
The cloned vector containing the sucas12a2 gene was transformed into
Escherichia coli BL21 (DE3) chemically competent cells (Novagen). From the
transformation plate, a colony was picked and placed into 1 L of prepared ZY
Autoinduction media in a 2.8 L baffled flask (Studier, 2015). Cells are grown for 5 hours
at 37°C 200 RPM in a shaking incubator. After 5 hours or when cells were turbid, the
temperature was dropped to 24°C for 24 hours. The cells were then harvested via highspeed centrifugation and stored at -80°C. All mutants were expressed in the same
manner.
Cells were homogenized on ice with 8 mL/gram lysis buffer (25 mM Tris pH 7.2,
0.5 M NaCl, 10% glycerol, 2 mM MgCl2, 10 mM imidazole, 1 mM Tris [2-carboxyethyl]
phosphine hydrochloride (TCEP)). The protease inhibitors 1000 x Aprotinin (0.5
mg/mL), 1000 x Leupeptin (0.5 mg/mL), 1000 x Pepstatin A (0.7 mg/mL), & 150 x
phenylmethylsulphonyl fluoride (PMSF) (25 mg/mL) and 0.25 mg/mL lysozyme were
added prior to cell lysis. Cells were incubated on ice for 20 minutes. Probe sonication for
cell lysis was performed at settings of 5/50. The lysate was then clarified by high-speed
centrifugation at 16 K RPM for 35 minutes.
All purification steps were performed at 4°C. The supernatant was loaded onto a
nickel affinity column (Nickel His trap FF crude, GE Healthcare) that had been preequilibrated with lysis buffer. The column was washed with 50-fold dilution of nickel
elution buffer (25 mM Tris pH 7.2, 0.5 M NaCl, 10 % glycerol, 2 mM MgCl2, 500 mM
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imidazole, 1 mM TCEP) and then eluted. Fractions with SuCas12a2 were pooled. Protein
was loaded onto a desalting column (HiPrep 26/10 Desalting, GE Healthcare) that had
been pre-equilibrated into a low salt buffer (25 mM Tris pH 7.2, 50 mM NaCl. 10 %
glycerol, 2 mM MgCl2, 1 mM dithiothreitol (DTT)), and then SuCas12a2 fractions were
loaded onto the column. Protein elution was collected and run over an IEX column
(HiTrap SP HP cation exchange, GE Healthcare). The column was washed with a 20-fold
dilution of the high salt buffer. The protein was eluted into a high salt buffer (25 mM Tris
pH 7.2, 1 M NaCl, 10 % glycerol, 2 mM MgCl2, and 1 mM DTT) using a linear gradient
of 5-100 % high salt buffer. Samples were spun down using a spin concentrator
(Corning® Spin-X® UF 100 MWCO) for placement on a size exclusion column (HiLoad
26/600 Superdex 200 pg., GE Healthcare). Protein was eluted into a final buffer (100 mM
HEPES pH 7.2, 150 mM KCl, 2 mM MgCl2, 1 mM TCEP, 10 % glycerol). Protein
samples were concentrated and stored at 4°C.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), and the appropriate extinction coefficient was applied (Table B-1).

SuCas12a2+gRNA Expression and Purification
The cloned vector containing the sucas12a2 gene and the CRISPR array was
transformed into Escherichia coli BL21 NiCo (DE3) chemically competent cells
(Novagen). From the transformation plate, a colony was picked and placed into an
overnight outgrowth. 1 L of Terrific Broth pH 7.2, supplemented with 2 mL 1000 x
Metals Mix and 1 mL MgSO4, in a 2.8 L flask was inoculated with 10 mL overnight
starter (Studier, 2015). Cells were grown to an optical density of 0.6 OD600 at 37°C 200
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RPM in a shaking incubator. When OD600 is reached, the cells were induced with 0.1 mM
IPTG (isopropyl B-D-1-thiogalactopyranoside), and the temperature was dropped to
18°C for 15 hours. The cells were then harvested via high-speed centrifugation and stored
at -80°C. All mutants were expressed in the same manner.
Cells were homogenized on ice with 8 mL/gram lysis buffer (25 mM Tris pH 7.2,
0.5 M NaCl, 10 % glycerol, 2 mM MgCl2, 10 mM imidazole, 1 mM Tris [2carboxyethyl] phosphine hydrochloride (TCEP)). The protease inhibitors 1000 x
Aprotinin (0.5mg/ml), 1000 x Leupeptin (0.5 mg/ml), 1000 x Pepstatin A (0.7 mg/ml), &
150 x phenylmethylsulphonyl fluoride (PMSF) (25 mg/ml) and 0.25 mg/ml lysozyme
were added prior to cell lysis. Cells were incubated on ice for 20 minutes. Probe
sonication for cell lysis was performed at settings of 5/50. The lysate was then clarified
by high-speed centrifugation at 16 K RPM for 35 minutes.
All purification steps were performed at 4°C. The supernatant was loaded onto a
nickel affinity column (Nickel His trap FF crude, GE Healthcare) that had been preequilibrated with lysis buffer. The column was washed with 50-fold dilution of nickel
elution buffer (25 mM Tris pH 7.2, 0.5 M NaCl, 10 % glycerol, 2 mM MgCl2, 500 mM
imidazole, 1 mM TCEP) and then eluted. Fractions with SuCas12a2 were pooled. Protein
was loaded onto a desalting column (HiPrep 26/10 Desalting, GE Healthcare) that had
been pre-equilibrated into a low salt buffer (25 mM Tris pH 7.2, 50 mM NaCl, 10 %
glycerol, 2 mM MgCl2, 1 mM dithiothreitol (DTT), and then SuCas12a2 fractions were
loaded onto the column. Protein elution was collected and run over an IEX column
(HiTrap Q HP cation exchange, GE Healthcare). The column was washed with a 20-fold
dilution of the high salt buffer. The protein was eluted into a high salt buffer (25 mM Tris
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pH 7.2, 1 M NaCl, 10 % glycerol, 2 mM MgCl2, and 1 mM DTT) using a linear gradient
of 5-100 % high salt buffer. Samples were spun down using a spin concentrator
(Corning® Spin-X® UF 100 MWCO) for placement on a size exclusion column (HiLoad
26/600 Superdex 200 pg., GE Healthcare). Protein was eluted into a final buffer (100 mM
HEPES pH 7.2, 150 mM KCl, 2 mM MgCl2, 1 mM TCEP, 10 % glycerol). Protein
samples were concentrated and stored at 4°C.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), and the appropriate extinction coefficient was applied (Table B-1).

Pre-crRNA Processing Assay
692 nM SuCas12a2 and 25 picomoles or 300 CPM of pre-crRNA (80 nt.) were
incubated at 37°C in NEB buffer 3.1. 10 µL aliquots were removed at time points
between 0-60 minutes, quenched with 10 µL phenol-chloroform, mixed, added 5 µL of
water followed by more mixing, and then centrifuged. The aqueous layer was removed
from the phenol, mixed with RNA loading buffer, and resolved on a 12% Denaturing (7
M urea) PAGE gel with a 30 bp. marker. The gel was dried and then exposed to a
phosphoscreen before being imaged on a Typhoon imager. Cleaved and uncleaved
fractions were quantified using ImageLab software as a function of % band cleaved. The
triplicate gels for analysis had samples that remained in the well, and this band was not
included in gel analysis. The data is the average of at least three experiments, and the
error bars represent the standard deviation from the mean. The ∆KRR_AAA mutant was
assessed using the same methodology as wildtype.
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DNA Binding Assays
5' 32P labeled DNA with a TTTC protospacer adjacent motif was exposed to
increasing concentrations of SuCas12a2 RNP complex (0-10 µM) in NEB Buffer 3.1 and
allowed to incubate for 30 minutes at 37 °C. Samples were then run on a 12% native
PAGE gel. Bound and unbound bands were quantified using ImageLab software as a
function of % band bound. Reported data is as follows: dsDNA binding was analyzed for
two replicates, and the ssDNA was analyzed with only one replicate. Error bars, when
present, represent the standard deviation from the mean. See Table B-2 for substrates.

DNA Cleavage Assays
5’ FAM-labeled ssDNA with a TTTC PAM was exposed to 500 nM SuCas12a2
RNP complex in NEB Buffer 3.1. Time points were quenched in basic phenol-chloroform
and then treated with RNAse A. Samples were removed from the top layer of the phenolchloroform mixture, mixed with 2x formamide loading dye, and run on a 15% denaturing
PAGE gel. See Table B-2 for substrates.

Negative Stain & Cryo-EM of SuCas12a2
Methodology for the negative stain and cryo-electron microscopy of SuCas12a2
are available through the David Taylor lab.

SAXS-SEC of Cas12a2
Dr. Robert Rambo performed small-angle x-ray scattering size exclusion
chromatography (SAXS-SEC) at the Diamond Light Source. The complete methodology
can be obtained from him. In brief, Cas12a2 was purified in the presence of 0.1%
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TWEEN 20 and then desalted into a storage buffer (100 mM HEPES pH 7.2, 150 mM
KCl, 1 mM TCEP, 1 % glycerol, and 2 mM MgCl2) and was placed over a Shodex KW403 column for SAXS-SEC analysis.

Negative Stain SmCas12a2
Negative stain images of SmCas12a2 were generated through a collaboration
between Hannah Domgaard and Dr. David Timm at the University of Utah's Cryo-EM
facilities. Hannah Domgaard prepared the protein samples. SmCas12a2 was desalted into
NEB Buffer 3.1 prior to grid plating. The method below was written and developed by
Dr. Timm.
Grids were glow discharged for 30 seconds. A 3.5 µL drop of the sample was
applied to the grid for each sample. Samples were incubated on the grid at room
temperature for 30 seconds. Grids were sequentially washed with 20 µL of NaCl & 20 µL
of 150 mM NaCl (2-5 sec wash times), with filter paper blotting after each wash. Grids
were stained with 10 µL 0.75% uranyl formate (UF) for 2-5 seconds, blotted, stained with
another 10 µL 0.75% UF for 2-5 seconds, blotted, then allowed to dry in air. Imaging was
on a T12 microscope. Search images were taken at 2,700 x magnification; exposure
images were taken at 30,000 x magnification.

Cloning of Wadjet
Developed primers to PCR amplify Wadjet-associated genes out of organisms
housed within the Department of Chemistry & Biochemistry at Utah State University.
These organisms are Mycobacterium MCS. and Azotobacter vinelandii DJ995. 5 µL of
glycerol stock cell culture with 100 µL water were added together and then heat-treated
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for 10 minutes at 95°C for use as a DNA substrate in the Q5 PCR kit from New England
Biolabs. Ligation Independent Cloning (LIC) was used to transfer Wadjet genes into
expression vectors. Reference Table B-5 for primers and Table B-6 for constructs
generated.

Expression & Purification of 2ST Av JetB
The cloned vector containing the Sumo-HIS AvJetB gene was transformed into
Escherichia coli BL21 Tuner (DE3) chemically competent cells (Novagen). From the
transformation plate, a colony was picked and placed into an overnight outgrowth. 500
mL of Luria-Bertani medium in a 2.8 L flask was inoculated with 10 mL overnight
starter. Cells were grown to an optical density between 0.6-0.7 OD600 at 37°C 200 RPM
in a shaking incubator. When OD600 was reached, the cells were induced with 1 mM
IPTG, and the temperature was dropped to 18°C for 18 hours. The cells were then
harvested via high-speed centrifugation and stored at -80°C.
Cells were homogenized on ice with 5-8 mL/gram lysis buffer (25 mM Tris pH
7.4, 0.5 M NaCl, 10 % glycerol, 2 mM MgCl2, 10 mM Imidazole, 1 mM DTT). The
protease inhibitors 1000 x Aprotinin (0.5 mg/ml), 1000 x Leupeptin (0.5 mg/ml), 1000 x
Pepstatin A (0.7 mg/ml), & 150 x PMSF (25 mg/ml) and 0.25 mg/ml lysozyme were
added prior to cell lysis. Probe sonication for cell lysis was performed at settings of 5/50
for five minutes. The lysate was then clarified by high-speed centrifugation at 16 K RPM
for 25 minutes.
All purification steps were performed at 4°C. The supernatant was loaded onto
nickel resin in a gravity flow column that had been pre-equilibrated with lysis buffer. The
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lysate was allowed to batch bind with the resin for 1 hour in the cold room on a shaking
platform. The column was washed with wash buffer (25 mM Tris pH 7.4, 2 M NaCl,
10 % glycerol, 2 mM MgCl2, 25 mM Imidazole, 1 mM DTT) and then washed with lysis
buffer. Protein sample was then eluted with Ni elution buffer (25 mM Tris pH 7.4, 0.5 M
NaCl, 10 % glycerol, 2 mM MgCl2 0.5 M Imidazole, 1 mM DTT). Fractions with AvJetB
were pooled. Protein was loaded onto a desalting column (HiPrep 26/10 Desalting, GE
Healthcare) that had been pre-equilibrated into a low salt buffer (25 mM Tris pH 7.4, 50
mM NaCl, 10 % glycerol, 2 mM MgCl2, 1 mM DTT), and then AvJetB fractions were
run over the column. Protein elution was collected and run over an IEX column (HiTrap
Q HP anion exchange, GE Healthcare). The column was washed with 15% high salt
buffer (25 mM Tris pH 7.4, 1 M NaCl, 10 % glycerol, 2 mM MgCl2, 1 mM DTT). The
protein was eluted into 100 % high salt buffer. Samples were spun down using a spin
concentrator (Corning® Spin-X® UF 100 MWCO) for placement on a size exclusion
column (HiLoad 26/600 Superdex 200 pg., GE Healthcare). Protein was eluted into a
final buffer (50 mM HEPES pH 7.4, 75 mM KCl, 1 mM MgCl2, 1 mM DTT, 5 %
glycerol). Protein samples were concentrated and stored at 4°C.
Protein concentration was determined by UV-Vis spectroscopy (Thermofisher
UV-vis Nanodrop), and the appropriate extinction coefficient was applied (Table B-1)

Far-UV Circular Dichroism (CD)
Far-UV CD spectra were collected for ApoSuCas12a2, SuCas12a2 RNP,
SuCas12a2 ∆KRR_AAA, Sumo-HIS AvJetB, and AvJetB. All data were collected using
a JASCO model J-1500 spectropolarimeter. CD spectra were collected from 190 to 260
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nm at 10 °C using 0.1 cm quartz cuvettes, 0.5 nm data sampling, a 50 nm/min scan rate,
and a 1-second data integration time. Measurements were performed at 0.5 (suCas12a2)
and 0.79 (JetB) mg/mL protein concentration, and CD signals were normalized by
converting to mean residue molar ellipticity. All proteins were placed in PBS for
analysis. Results for SuCas12a2, N-Sumo-HIS AvJetB, were collected once, and cleaved
tag AvJetB data were collected in triplicate.

Results

Protein Expression & Purification
To biochemically and structurally characterize Cas12a2 proteins, Apo and gRNA
bound SmCas12a2 and SuCas12a2 were recombinantly expressed and purified from E.
coli DE3 cells (Figure 3-3). Initially, concentrations of purified protein were sufficient for
biochemical assays but not for x-ray crystallography techniques. This finding led to the
pursual of alternative techniques that would provide structural data, such as size
exclusion small-angle x-ray scattering (SAXS-SEC) and cryo-electron microscopy.

SAXS of Cas12a2
Protein samples were sent for small-angle x-ray scattering to provide lowresolution data on the conformational arrangement of protein samples, for instance to
determine conformational differences between ApoCas12a2 and gRNA bound Cas12a2.
SAXS-SEC analysis revealed that all Cas12a2 proteins were soluble but trapped in a
detergent micelle, presumably TWEEN 20 (Figure B-1). This detergent was initially
included in our protein preparations in an attempt to purify more soluble protein, as most
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Figure 3-3
Protein Purification of Type V-A2 Proteins

Note. SDS-PAGE gels showing purified Apo SuCas12a2, SuCas12a2 bound to a guide
RNA, and Apo SmCas12a2.
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of our expressed protein at the time remained in the cell pellet after lysis. It was
unanticipated for our purified protein to be trapped in a micelle. This information led to
the development of alternative Cas12a2 protein purification techniques.

Negative Stain SmCas12a2
SmCas12a2 was prepared for negative stain analysis to assess whether cryoelectron microscopy could be used to solve the molecular structure. Negative stain data
collected at the University of Utah show that the SmCas12a2 RNP complex is a monomer
in solution, with particles ranging from 7 nm to larger. The monodisperse particles show
that SmCas12a2 is a viable candidate for cryo-electron microscopy (Figure 3-4).

Cryo-EM of SuCms1
Collaboration with the David Taylor lab at UT-Austin led to the generation of
negative stain data, 2-D forward projections, and a low resolution 4 Å electron density
map of the SuCas12a2 RNP complex (Figure 3-5). The 2-D forward projections allowed
for comparison of ApoSuCas12a2 and SuCas12a2 RNP, showing a global conformational
rearrangement when bound to the guide RNA. Model building into the 4 Å map resulted
in the placement of identifiable secondary structure elements such as alpha helices and an
A-form RNA into density representative of where the direct repeat portion of the guide
RNA is bound. The model building of the RNP complex halted when it became apparent
that the connectivity of the electron density would be insufficient to place a backbone of
the structure through the density. Attempts to dock Cas12a models into the density did
not provide enough structural insight to continue modeling the RNP complex.

105
Figure 3-4
SmCas12a2 RNP Negative Stain

Note. Purified SmCas12a2 was prepared for negative staining using uranyl formate.
Using a T12 microscope, search images were taken at 2,700x magnification, exposure
images were taken at 30,000x magnification.
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Figure 3-5
SuCas12a2 Low Resolution Map and Model

Note. A. Negative stain and 2D particle classification of Apo and RNP SuCas12a2
generated by the Taylor lab B. 2D forward projections of Apo and RNP SuCas12a2
generated by the Taylor lab. C. Cryo-electron density generated maps with modeled
secondary structure and A-form RNA.
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Pre-crRNA Processing
One of the critical stages for CRISPR immunity is processing a long pre-crRNA
into smaller guide RNAs. Without this step, no ribonucleoprotein complexes will
assemble which means that no targeting of foreign nucleic acid will occur. Using
denaturing PAGE gels and a radiolabeled substrate, we show that ApoSuCas12a2 will
process an 80 nt. pre-crRNA into a 30 bp gRNA (Figure 3-6). In-gel densitometry
analysis shows that SuCas12a2 processed ~30% of the pre-crRNA. It is possible that the
substrate utilized was non-optimal, as it was not a full pre-crRNA transcript composed of
multiple direct repeat and spacer sequences. Alternatively, it is possible that the number
of active SuCas12a2 molecules was low given that we utilized upwards of 500 nM
protein. Dr. Crowley performed analysis of the processed gRNA and identified the exact
cleavage site via a reverse transcriptase PCR reaction. She found that cleavage occurs
upstream of the 2nd predicted RNA stem-loop in the direct repeat (Dmytrenko et al.,
2022).
To further understand the mechanism of biogenesis used by SuCas12a2, we
identified the biogenesis active site in the N-terminal region of the protein. Cas12a2
proteins share sequence similarities in the N-terminus, knowing this we generated an ITASSER homology model, which referenced the PDB deposition 5NG6 of FnCas12a
bound to RNA (Figure B-2) (Yang et al., 2014; Swarts et al., 2017). FnCas12a utilizes
histidine and lysine residues to process a guide RNA. Knowing that basic amino acids
form a biogenesis active site in Cas12a, we looked at the N-terminal region of the ITASSER Cas12a2 homology model and identified lysine and arginine residues that could
play a role in SuCas12a2 biogenesis (Figure 3-7). The residues K791, R792, and R795
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Figure 3-6
SuCas12a2 crRNA Processing and Secondary Structure Validation

Note. A. Denaturing PAGE analysis shows that SuCas12a2 processes a guide RNA. B.
Graph depicts % guide RNA cleaved as a function of time. C. Denaturing PAGE analysis
shows that mutation of residues KRR into AAA abolishes processing activity. D. Bar
graph analysis depicts % guide RNA cleaved between WT SuCas12a2 and ∆KRR_AAA
SuCas12a2. E. Far UV Circular Dichroism analysis shows that ∆KRR_AAA SuCas12a2
maintains the same level of structural integrity as SuCas12a2.
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Figure 3-7
Model Used for the Development of RNA Processing Mutants

Note. A. 5NG6 FnCas12a bound to an RNA guide with the RNA processing residues
highlighted in green. B. ITASSER homology model of SuCas12a2 modeled with the
RNA from 5NG6 with the residues presumed to be important for RNA processing in
green.
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were selected and mutated to alanines based on their position in the active site as well as
their charge. The secondary structure of this mutant was assessed via circular dichroism.
RNP. The triple mutant was assessed for activity alongside WT SuCas12a2 and was
deficient in processing the long pre-crRNA, with less than 20 % of the pre-crRNA being
cleaved, confirming the role of the KRR residues in biogenesis. This work is significant
as the residues responsible for biogenesis, a key step in CRISPR immunity, were
identified.

Far- UV Circular Dichroism (CD) of SuCas12a2
Far-UV circular dichroism (CD) was performed on ApoSuCas12a2, SuCas12a2
RNP complex, and SuCas12a2 ∆KRR_AAA to assess structural integrity. All showed
similar CD profiles, which indicated a largely alpha-helical structure. Furthermore, the
similarities between spectra suggest that the proteins remain similarly folded and that the
lack of activity we see for the ∆KRR_AAA in the crRNA processing assays is a result of
the amino acid mutations and not a result of disrupting the secondary structure of the
protein (Figure 3-6). It is from these results that we can have confidence in our
bioprocessing residue selections and purification methods.

DNA Binding Assays
To understand how Cas12a2 could generate dsDNA breaks in Oryza sativa, we
needed to understand what the substrates for the ribonucleoprotein complex were
(Begemann et al., 2017). This involved in vitro studies of the interference aspect of
CRISPR immunity. For interference to occur, binding to a nucleic acid substrate must
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occur, so DNA binding assays using 5’ P32 labeled dsDNA and 5’ FAM-labeled ssDNA
on native PAGE gels were conducted. Data show that Cas12a2 can bind both single
stranded and double-stranded DNA with a TTTC PAM. The data collection and analysis
were not performed in triplicate as DNA nuclease activity sporadically appeared; thus, a
Kd analysis could not be performed. However, visual analysis indicates that high
concentrations of Cas12a2 in the upper nanomolar to lower micromolar are needed for
dsDNA binding (Figure 3-8).

DNA Cleavage Assays
After substrate binding, interference is typically achieved via cleavage event. It is
for this reason that in vitro DNA cleavage assays were utilized to determine the
molecular mechanism of SuCas12a2 interference. Native PAGE gels intended to show
binding of SuCas12a2 to 5’P32 labeled duplexed nucleic acid showed both binding and
cleavage (Figure 3-9). However, this cleavage activity was sporadic and protein
preparation dependent. Denaturing PAGE gels assaying cleavage of single-stranded DNA
with a TTTC PAM also showed cleavage; yet again, this cleavage activity was sporadic
and protein preparation dependent (Figure 3-9). Attempts to determine exact cleavage
conditions were unsuccessful and included the use of a variety of buffers, DNA
substrates, concentrations of substrates and proteins, times, reductants, and RuvC mutant
analysis (data not shown). Under no condition tested did were consistent cleavage
conditions identified. It was later revealed in work performed by Dylan Keiser, that the
first interference substrate of Cas12a2 is RNA and that after target RNA is bound by the
ribonucleoprotein complex, indiscriminate cleavage of ssRNA, ssDNA, and dsDNA can
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Figure 3-8
SuCas12a2 Binds DNA Substrates

Note. A. Native electromobility shift assays show that SuCas12a2 RNP can bind both 5’
P32 single stranded and duplexed DNA substrates. B. Graph shows % bound doublestranded DNA as a function of SuCas12a2 concentration. Error bars represent standard
deviation between two data sets. C. Graph shows % bound single stranded DNA as a
function of SuCas12a2 concentration. There are no error bars as only one gel was
sampled.as12a2 concentration. Error bars represent standard deviation between two data
sets. C. Graph shows % bound single stranded DNA as a function of SuCas12a2
concentration. There are no error bars as only one gel was sampled.
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Figure 3-9
SuCas12a2 Cleaves and/or Degrades DNA

Note. A. Native electromobility PAGE analysis intended to show binding to double
stranded 5’ P32 DNA. Increasing concentrations of SuCas12a2 RNP correlate with
increasing band intensity of a cleaved/degraded product. B. Denaturing PAGE gel
showing cleavage of a 5’ FAM labeled single stranded DNA substrate.
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occur (Dymetrenko et al., 2022).

Wadjet Cloning, Protein Purification, & Structure Prediction
Prokaryotic species containing Wadjet defense systems were identified in the
department using the extensive bioinformatic search performed by the Sorek lab (Doron
et al., 2018). All three genes from Azotobacter vinelandii DJ and Mycobacterium MCS
were successfully cloned into LIC expression vectors using LIC cloning (Table B-5; B6). The Sumo-HIS AvJetB was the only Wadjet gene for which expression and
purification conditions were established. SDS-PAGE analysis shows that Sumo-HIS
AvJetB purifies at a molecular weight of 48 kDa, and after TEV tag cleavage, AvJetB
runs at a molecular weight close to 25 kDa. Size exclusion chromatography shows that
cleaved tag AvJetB elutes with an elution volume equivalent to a protein near 48 kDa,
showing that AvJetB purifies as a dimer. This is the first in vitro data showing
dimerization of a Wadjet associated protein. Circular dichroism of tagged and cleaved tag
AvJetB shows no loss of secondary structure after TEV cleavage of the large SUMO-HIS
tag (Figure 3-10).

Discussion
The type V-A2 Cas12a2 proteins had previously been shown to cause
insertion/deletion events in Oryza Sativa. However, the mechanism behind the targeted
double stranded DNA breaks was unknown. The work performed in this thesis provided
some of the first attempts to characterize Cas12a2 proteins in vitro. Initial attempts to
structurally analyze Cas12a2 proteins from Smithella and Sulfuricurvum sp. PC08-66
resulted in SAXS data confirming the presence of micelles in protein purifications. This
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Figure 3-10
Recombinantly Expressed and Purified AvJetB is a Dimer

Note. A. SDS PAGE gel of N-terminal Sumo-HIS tagged AvJetB (~48 kDa.) off a size
exclusion column. B. SDS PAGE of TEV treated N-term. Sumo-HIS AvJetB (Cleaved
Tag; ~25 kDa.) off a size exclusion column. C. Far-UV Circular dichroism showing the
maintenance of structural integrity between tagged and cleaved tag JetB. D. Size
exclusion chromatogram of cleaved tag AvJetB eluting with an elution volume equivalent
to a dimer ~49 kDa.
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led to the removal of detergents from future protein protocols. Negative stain analysis of
SmCas12a2 showed a monodisperse particle optimal for cryo-electron microscopy
techniques. As expression and purification conditions for SmCas12a2 have been
identified, this protein should be selected for future cryo-electron microscopy pursuits as
it may harbor differences from SuCas12a2.
SuCas12a2 structural analysis led to the development of negative stain data, 2D
forward projections showing global conformational rearrangements between Apo and
RNP complex, and a low-resolution map in which some secondary structures could be
modeled. Although the attempts to build a model of SuCas12a2 were insufficient here,
the work discussed in this thesis provided the foundation for others in the Jackson and
Taylor labs to generate a high-resolution map of SuCas12a2 bound to nucleic acid
substrates (Bravo et al., 2022).
In vitro analysis geared towards understanding the bioprocessing stage of
CRISPR immunity showed that SuCas12a2 processed a long pre-crRNA into a short 30
bp guide RNA. Although in-gel densitometry revealed that only ~30% of substrate was
cleaved. This low cleavage rate could be because the pre-crRNA substrate used in these
assays was a truncated pre-crRNA composed of only one direct repeat sequence and
spacer, rather than the biologically relevant pre-crRNA composed of multiple direct
repeats and spacers. Alternatively, protein preparation, storage, and reaction
concentrations could have played a role in the low percent cleavage. Perhaps using nonfrozen protein or higher concentrations of protein would have resulted in higher
percentages of cleaved nucleic acid. Successful visualization of bioprocessing led to the
identification of the bioprocessing active site.
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The amino acids KRR (751,752, and 755 respectively) were identified as catalytic
candidates in the biogenesis active site and were found to be vital for processing activity
as mutating these residues into alanines substantially lowered RNA cleavage. Dr. Val
Crowley demonstrated later through reverse transcriptase PCR that the pre-crRNA is
processed between two adenosine residues on the 5’ end of the second hairpin of the
direct repeat (Dmytrenko et al., 2022). The work performed here is significant, as it has
elucidated the mechanism of bioprocessing for SuCas12a2. Additionally, if Cas12a2 is to
be repurposed as a tool for gene therapeutics or genome engineering, knowledge of
gRNA requirements is needed in order to correctly assemble the tool in vitro.
After determining the parameters for gRNA processing, the requirements for
CRISPR interference were explored through DNA binding and cleavage experiments. In
vitro analysis showed that SuCas12a2 could bind both duplexed and single-stranded
DNA, although binding affinity appeared to be in the hundreds of nM, suggesting that the
PAM sequence used in our assays was non-optimal, or that an alternative binding
substrate was preferred. Additionally, binding activity of SuCas12a2 to DNA was
intermittently accompanied by nuclease activity, resembling cleavage products of CasX,
a fellow member of the type V family of proteins (Liu et al., 2019). This nuclease
activity sometimes resembled DNA degradation when witnessed with dsDNA and a
single cut site when with ssDNA. However, none of the cleavage activity was
consistently reproducible between protein purifications leading us to believe that we had
either purified contaminating nucleases or had not identified the appropriate conditions to
determine the biochemical parameters for DNA cleavage.
The SuCas12a2 project was passed from my hands to Dylan Keiser two years ago.
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Since then, Dylan Keiser was able to identify the biologically relevant RNA substrate and
show RNA-guided RNAse activity (Dmytrenko et al., 2022). He utilized RuvC nuclease
motif mutants to break RNAse activity and demonstrated that after SuCas12a2 binds and
cleaves the target RNA substrate, it will begin cleaving DNA and RNA indiscriminately.
From his work, the data behind the indiscriminate DNA cleavage in the Jackson lab
began to make sense. Perhaps DNA would get caught in a suitable conformation for
cleavage without a target RNA first being bound. Perhaps there was prep-dependent
activity in which proteins would be purified with contaminating RNAs that SuCas12a2
could bind and use to turn on the indiscriminate DNAse activity. The study of SuCas12a2
is vital as it provides a new tool for medical scientists, genome engineers, and researchers
to harness the power of a reprogrammable nuclease capable of targeting specific RNA
sequences.
Wadjet systems have been found to inhibit plasmid transformation in B. subtilis,
however the mechanism behind that inhibition was unknown, additionally structures of
Wadjet system proteins are unknown as well. Initial homology searches of these proteins
suggested secondary structure similarities with condensin complexes, suggesting roles in
DNA binding and segregation. It is with this knowledge that the Wadjet systems from A.
vinelandii DJ and Mycobacterium MCS were cloned into LIC expression vectors. The
AvJetB protein was successfully expressed and purified through the use of affinity and
size exclusion chromatography. Size exclusion chromatography revealed that AvJetB was
purified as a dimer. Dimerization was not unanticipated, as condensin complexes
typically form hetero and homo dimeric complexes (Rybenkov et al., 2014). This work
supports the hypothesis that Wadjet systems will form similar dimeric complexes. The
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cloning performed on the jet genes set the groundwork for a successful project studying a
plasmid inhibition system as rapid testing of expression conditions could result in the
purification of the JetA and JetC proteins. With all protein components assembled, proper
study of the Wadjet complex could be pursued through ATPase and DNA binding assays.
In conclusion, the study of Cas12a2 has laid down important foundational work
on variant CRISPR immune systems. If these systems are studied further, they could
provide insight into microbial immune systems and provide new tools for nucleic acid
recognition and manipulation. Specifically, there are many diseases whose roots are due
to genetic defects. The use of a reprogrammable nuclease, such as Cas12a2, could
provide alleviation from genetic disease, such as cystic fibrosis, through gene therapy
(Maule et al., 2020). Although there are many CRISPR-Cas proteins that are already
being pursued for such ventures, Cas12a2 may provide a more suitable tool in certain
conditions. The continued study of JetB and the other jet genes, could result in
knowledge regarding plasmid control and sharing within microbial communities. This
information can provide context for why some plasmids are successfully shared within a
community rather than others.
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CHAPTER 4
SUMMARY & FUTURE DIRECTIONS

Introduction
The work presented in this thesis provides a basic characterization of the type IVA CasDinG enzyme, presents preliminary data on the type IV-A RNP complex, and lays
a foundation for understanding the type V-A2 protein SuCas12a2 and the Wadjet
complex from Azotobacter vinelandii.
In Chapter 1, three microbial immune systems were introduced, the type IV-A
CRISPR-Cas system, the type V-A2 CRISPR-Cas system, and the Wadjet system.
CRISPR-Cas systems are adaptive and heritable prokaryotic immune systems that defend
against mobile genetic elements, while Wadjet systems have been shown to defend
against plasmids. The motivation for studying these systems was to discover their
biochemical mechanisms and structures through in vitro analyses, which would provide
key insight into how prokaryotes defend against infectious viruses and proteins. The
work presented in this thesis provides pivotal information on three prokaryotic immune
systems which could result in new genome editing tools and an enhanced understanding
of the diversity of microbial immune systems.
In Chapter 2, a detailed investigation of the CasDinG protein was conducted,
resulting in a thorough biochemical characterization of the first 5’-3’ ATP dependent
CRISPR-associated helicase as well as details the first structure of a CRISPR-associated
DinG helicase. Furthermore, size exclusion chromatograms and SDS PAGE showed the
formation of a transient complex between CasDinG and the type IV-A RNP complex.
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This is the first data showing that CasDinG is a functional helicase, providing key
information on a protein which is essential for type IV-A CRISPR system functionality.
In Chapter 3, the initial biochemical and structural characterizations performed on
type V-A2 Cas12a2 proteins were presented. These data revealed that SuCas12a2 can
process a gRNA from a long pre-crRNA utilizing lysine and arginine residues in the
bioprocessing active site. Furthermore, cryo-EM data showed that SuCas12a2 undergoes
a global conformational rearrangement upon gRNA binding. This work laid the
foundation for others to decipher the biochemical basis of CRISPR interference in type
V-A2 systems. With this knowledge, SuCas12a2 may be repurposed for use as an RNAguided nuclease, adding another Cas protein to the genome editing toolbox. Work on the
type V systems was followed by the presentation of preliminary data on the Wadjet
system A. vinelandii. Size exclusion chromatogram analysis showed evidence of AvJetB
dimer formation which supports the hypothesis the Wadjet systems are related to
chromatin condensin complexes. Additionally, the cloning performed on these Wadjet
systems provides a path for others to characterize Wadjet proteins from either
Azotobacter vinelandii or Mycobacterium MCS, which could provide novel information
on plasmid defense systems.

Type IV-A Summary & Future Directions
Assays which assessed nucleic acid binding preferences, ATPase hydrolysis rates,
helicase polarity, and in vivo functionality were utilized in order to provide basic
characterization of this enzyme.
To understand CasDinG nucleic acid preferences, binding assays were performed
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which showed that CasDinG could bind both DNA and RNA with similar affinities. DNA
binding assays with ATP and analogs showed that the binding affinity of CasDinG for
ssDNA did not change substantially, indicating that ATP binding does not enhance
affinity for nucleic acid substrates.
Binding assays were followed by ATPase assays to determine whether CasDinG
ATPase activity was stimulated by nucleic acid. Michaelis-Menten kinetics revealed that
CasDinG hydrolyzes 32 ATP sec-1 with ssDNA and 22 ATP sec-1 with PT-RNA
substrates. These DNA ATPase rates are similar to values reported for E. coli DinG
(Voloshin et al., 2003). The phosphorothioated RNA (PT-RNA) substrate was utilized
rather than an RNA substrate when we encountered RNAse activity in our assays. The
phosphorothioated backbone protects against contaminating nuclease activity (Putney et
al., 1981). However, with the added protection of the RNA backbone, there is increased
steric strain from the addition of the sulfur group on the phosphate backbone resulting in
a less flexible backbone (Zhang et al., 2012). Whether or not the phosphorothioated
backbone inhibits hydrolysis of ATP will have to be assessed in the future through either
an RNA substrate in RNAse-free conditions or by incorporating fewer phosphorothioates
into the RNA substrate used as it is only with additional experimentation that a true
comparison of RNA to DNA ATPase rates could be evaluated.
Future ATPase assays could be performed in the presence of type IV-A RNP and
target nucleic acid sequences to assess whether there are increased rates of ATP
hydrolysis by CasDinG. Cas3 helicase/nuclease proteins have shown increased ATP
hydrolysis rates when introduced to the R-loop formed between the Cascade RNP
complex and the target sequence (Mulepati & Bailey, 2013).
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CasDinG can bind both ssDNA and ssRNA and hydrolyze ATP in their presence
but will only unwind duplexed nucleic acids, which contain a DNA overhang, despite
binding and hydrolyzing ATP in the presence of RNA. This data suggests that a more
thorough analysis of CasDinG function in regard to ssRNA may be prudent. Perhaps, in
addition to being a DNA helicase, CasDinG may be performing another functional role
with small RNAs.
CasDinG was identified as a 5’- 3' ATP-dependent helicase capable of utilizing an
array of divalent ions to displace duplexed nucleic acid, similar to other DinG enzymes
(Voloshin et al., 2003). Mg2+ is typically used in helicase reactions as it can be bound and
coordinated by the aspartate residue in the conserved Walker B (DEAH) helicase motif,
while the adjacent glutamate can function as a catalytic residue acting on the phosphate
backbone of ATP, which is being coordinated by the Mg2+ (Frick et al., 2007). The
research presented here shows that CasDinG can unwind nucleic acid using Mg2+, Mn2+,
Ca2+, Ni2+, and Co2+ but not Zn2+ or Cu2+. ATPase assays should be performed using zinc
and copper to rule out the lack of ATP hydrolysis as the reason for no unwinding. If ATP
can be hydrolyzed in the presence of Zn2+ or Cu2+, then the lack of displacement may be
protein destabilization or, alternatively, hyper-stabilization of duplexed nucleic acid
(Voloshin et al., 2003).
Time-course analysis of helicase activity showed quick unwinding of substrates
using 15 nM substrate and 25 nM protein. The quick unwinding suggests that a stop-flow
assay may be prudent in order to obtain more data points with various percentages of
substrate unwound. Alternatively, one could generate longer duplexes and perform native
PAGE analysis with the hope that longer duplexes would require longer incubation
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periods with CasDinG to be fully unwound.
In depth characterization of CasDinG as a helicase would provide information on
parameters such as a real kunwind. To perform a real kunwind analysis, one would need to set
up time constraints and then perform helicase reactions in triplicate for multiple
concentrations of CasDinG. This data would provide information on the rate of
unwinding for a given substrate, allowing the comparison of unwinding rates between
DinG enzymes and DinG substrates. This would allow for statements to be made in
regard to whether CasDinG preferentially unwinds duplex DNA or hybrid duplexes.
Some DinG enzymes have been found capable of unwinding G quadruplexes and
are recruited to DNA replication forks (Thakur et al., 2014). With this in mind, complex
nucleic acid structures such as Holliday junctions could be assessed as substrates for
CasDinG helicase activity. Additionally, the minimum length of single-stranded nucleic
acid needed as a loading zone for helicase activity should be tested, perhaps a longer
loading or shorter loading zone increases or decreases helicase function. This data would
provide crucial information on the requirements for CasDinG function in regard to type
IV-A CRISPR-Cas system immune function.
Mutational analysis of the accessory domains and Walker B motif revealed that
some domains are essential for robust ATPase activity (vFeS & Walker B motif) and
helicase activity (Walker B motif, Arch). The vFeS and Walker B mutants resulted in
inhibited ATPase rates in comparison to WT. Interestingly the vFeS mutant displayed
fairly robust helicase activity despite inhibited rates of ATP hydrolysis. The arch and
walker B mutations box displayed less unwinding in comparison to WT. Data regarding
the N-terminal truncation was ambiguous as different preparations of this mutant showed
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both unwinding and the lack thereof. Further biological replicates of each mutant are
advised, perhaps with adjustments to the size of the domain knock outs.
To provide enhanced understanding of the function of each accessory domain,
studies should migrate from whole domain mutations to single amino acid mutations.
Point mutations would require the identification of residues within each of the accessory
domains which could contribute to the ATPase, DNA binding, or DNA unwinding
activities of CasDinG. For instance, there is a glutamate aspartate pair at positions 271
and 272, which reaches into the nucleic acid binding pocket of CasDinG. These acidic
residues could be mutated to alanines and then assayed for their potential role in nucleic
acid remodeling, whether through direct interactions with nucleic acid or stabilization of
the ATP hydrolysis active site.
The structure of CasDinG was solved using x-ray crystallography and molecular
replacement. The structure revealed two accessory domains, the arch and vFeS and there
was no electron density to describe the N-terminus of the protein. Overall, structural
comparison of CasDinG to E. coli DinG revealed structural conservation of the helicase
core with slight modifications to the arch domain and confirmation of the lack of
coordinated Fe atoms in the vFeS domain. In the future, crystallization of a truncated
CasDinG structure containing only the N termini, or CasDinG bound to substrate
allowing for the N terminus to be resolved, would provide structural information on a
domain critical for immune system function. Expression conditions would have to be
evaluated as attempts to purify just the N-terminus using a WT CasDinG protein
expression profile were previously unsuccessful.
CasDinG will co-express and co-purify with the type IV-A RNP complex. The
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exact nature of their association is unknown as co-purification shows a transient complex.
Whether this transient complex is based on protein-protein contacts or through shared
nucleic acid substrates is unknown. In vitro assembly of purified type IV-A RNP
complex and CasDinG in the presence of various nucleic acid substrates followed by size
exclusion chromatography could provide information on the recruitment of CasDinG to
complex; alternatively, chemical cross-linking could be used to determine if there are
protein contacts in the absence of nucleic acid substrates. This has been done with other
type IV-A RNP complexes and DinG proteins successfully and may reveal the true nature
of the Pa83 CasDinG and type IV-A RNP association (Özcan et al., 2018).
Future structural analysis of CasDinG should include the crystallization of
CasDinG in the presence of substrates such as single-stranded DNA, single-stranded
RNA, ADP-BeF3, and perhaps even a stalled unwinding complex. Perhaps these substate
CasDinG structures could be assisted by the ApoCasDinG crystallization conditions that
provided crystal hits, Table A-7. The next step would be to obtain a type IV-A RNP
complex structure and/or a structure that included CasDinG with the RNP complex. It
may be beneficial to work towards performing cryo-electron microscopy with these large
complexes as that has previously been successful with other CRISPR-Cas complexes
isolated in the Jackson lab (Taylor, 2021; Zhou et al., 2021).
In order to more fully understand the P. aeruginosa strain 83 type IV-A RNP
complex, binding affinities for ssDNA with various PAM sequences were identified. All
ssDNA PAM sequences tested resulted in low nM binding affinities. As the in vivo
assays test for plasmid targeting, the assessment of binding affinities for duplexed nucleic
acid targets should be a top priority in future studies. Additionally, the type IV-A RNP
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complex showed indiscriminate plasmid nicking/linearization regardless of the presence
of CasDinG. Further in vitro assays are needed to determine whether this activity is the
result of contaminating nucleases or whether there are catalytic residues within the type
IV-A complex capable of causing breaks in nicked or duplexed nucleic acid. If the type
IV-A complex is indeed causing cleavage of nucleic acid, that would contrast with a
recent publication showing type IV-A immune function without DNAse activity (Guo et
al., 2022). Alternatively, if the type IV-A system houses nuclease activity, it may do so as
a requirement for CasDinG loading onto ssDNA. Knowledge of any nuclease activity
associated with the type IV- A immune system would provide critical data on the
interference phase of CRISPR immunity.
Overall, the studies performed on the type IV-A CRISPR-Cas system from P.
aeruginosa strain 83 in this thesis reveal a model in which the CasDinG enzyme acts a 5’
3’ ATP dependent helicase which could possibly be recruited to an R -loop generated by
the type IV-A RNP complex binding to a target plasmid. CasDinG could then perhaps
knock off RNA transcripts or proteins bound near the R-loop resulting in CRISPR
interference.

Cas12a2 Summary & Future Directions
The purification of multiple Cas12a2 proteins was discussed in this thesis and
SEC-SAXS data prompted changes to the purification protocols so that there would be no
contaminating detergents, trapping Cas12a2 proteins in micelles. This protocol change
allowed future Cas12a2 protein purifications to be more accurately assessed for activity
in vitro.
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Denaturing PAGE and radiolabeled substrates were used to show that SuCas12a2
processes a guide RNA and relies upon the KRR basic amino acids (positions 791, 792,
and 795) in the biogenesis active site for RNA processing. This information is important
as this information describes a pivotal step in CRISPR immunity, without guide RNA
processing there will be no targeted CRISPR interference.
We believed that Cas12a2 targeted DNA as previous work by collaborators
showed DNA editing in Oryza sativa (Begemann et al., 2017). It was with this
knowledge that PAGE analysis with radiolabeled DNA substrates were used to show that
SuCas12a2 can bind ssDNA and dsDNA. Sometimes these assays coincided with DNAse
activity and other times no DNAse activity was visualized. Because of the variability of
protein preparations, no real binding affinities were able to be assessed.
To determine whether SuCas12a2 was responsible for the DNAse activity seen
in the binding assays, nuclease assays were performed. The breadth of the nuclease
assays performed with target DNA was not discussed in detail in this thesis, however it
should suffice to say that temperatures, buffers, protein concentrations, and protein
preparation methods were all tested. It was thought that there was either a contaminating
nuclease responsible for the DNA cleavage seen in the binding assays or that we had not
identified the correct in vitro conditions for optimal target DNA cleavage. Later work
performed by Dylan Keiser explained the DNA nuclease activity. He found that RNA
was the primary Cas12a2 substrate, which, when bound, would activate indiscriminate
DNA and RNA cleavage using the catalytic RuvC motifs (Dmytrenko et al., 2022).
In the future a thorough biochemical analysis of SuCas12a2 determining binding
affinities and cleavage rates should be performed. This information would be pivotal in
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order to utilize SuCas12a2 as a tool for cell editing applications. For this to be
accomplished, binding affinities using nuclease deficient RuvC motif mutants will need
to be established for the target RNA sequence, and then DNA and RNA in trans. All
mutants generated by me, and others should be analyzed via circular dichroism to ensure
that the activity loss is due to the mutation itself and not the widespread loss of secondary
structure.
This thesis described preliminary structural analyses of Cas12a2 proteins.
Negative stain data and 2D classifications of ApoSuCas12a2 and SuCas12a2 RNP
showed a global conformation rearrangement of gRNA bound protein. Additionally, a
low-resolution map (4 Å) was generated for the RNP structure. This preliminary map and
structural work laid a foundation for the successful determination of a higher resolution
map and model prepared by Thom Hallmark and the Taylor lab (Bravo et al. 2022). This
high-resolution structure is currently being prepared for publication. Future attempts to
solve alternative structures of SuCas12a2 in apo form and as a ternary complex with
either DNA or RNA should be pursued.
The bioinformatics analysis performed by Benson Hill Biosystems highlighted
other Cas12a2 variants that may be of interest (Begemann et al., 2017). The biochemical
characteristics of ObCas12a2 may differ from that of SuCas12a2 and may provide an
alternative tool to the genome editing toolbox by highlighting an enzyme that is more or
less specific for particular nucleic acid substrates. Furthermore, the Smithella sp. SCADC
and Microgenomates sp. Cas12a2 genes are of interest as they are directly adjacent to
Cas12a genes and share a CRISPR array. An avenue of study that would be beneficial in
a broader sense would be to determine the biochemical basis of adaptation for the Type
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V-A2 systems, as there is no current data on adaptation from Type V systems.
Purification of SmCas12a2 has already been performed and resulted in the
collection of negative stain data showing monodisperse particles, implying that it is a
great candidate for future cryo-EM experiments. SmCas12a2 should be followed up on
with both structural and biochemical analysis. Experiments assessing whether both
Cas12a and Cas12a2 can process a pre-crRNA and perform interference would provide
clues as to whether these proteins interact directly or function as systems that
complement one another. For instance, if one system fails to target an infecting sequence,
the other system may be able to target and eliminate the infection.
In conclusion, my work on the Cas12a2 proteins resulted in the identification of
the bioprocessing active site in SuCas12a2. Furthermore, my work laid the foundation by
which others to discovered that SuCas12a2 is a reprogrammable RNA nuclease with trans
cleavage of both DNA and RNA, which results in widespread cell death due to the
indiscriminate DNA and RNA cleavage (Dmytrenko et al., 2022; Bravo et al., 2022). The
Jackson lab is currently trying to determine whether SuCas12a2 can be utilized in
eukaryotic cells as an RNA guided nuclease. This work is important as it could provide a
potential therapeutic tool, which targets cancer cells.

Wadjet Summary & Future Directions
The Wadjet genes from A. vinelandii DJ and Mycobacterium MCS have been
cloned into expression vectors. Recombinant expression and purification parameters for
AvJetB were identified, and size exclusion chromatography indicated that AvJetB
purifies as a dimer. This data is significant as it supports the hypothesis that Wadjet
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systems form dimeric complexes.
. Expression tests of AvJetC and AvJetA are needed in order to obtain protein for
single protein experiments such as DNA binding and ATPase assays. Once JetC is
purified, an immediate assessment of ATPase activity would be prudent, as this protein
shares structural similarity with MukB, an active ATPase (Doron et al., 2018; Zawadzka
et al., 2018). When expression/purification conditions are established for all Wadjet
proteins, experiments can be performed to determine whether the Wadjet system acts
similar to chromatin condensin complexes. Furthermore, the generation of mutants along
the dimer interfaces of all Jet proteins would allow us to determine where protein
interactions are occurring, and which residues are essential for DNA recognition and
binding.
The easiest method to move studies forward would be to finish the development
of a destination vector, which would house all three Av Wadjet genes allowing for coexpression of the Wadjet complex. Alternatively, generating tagless versions of the genes
and attempting to co-express utilizing multiple plasmids may yield results as this has
been successful with other Jackson lab projects (CasDinG + Type IV-A RNP Complex
purification). If the complex is successfully purified, crystal trays should be pursued as
there are no Wadjet structures in the PDB database. Analytical ultracentrifugation could
provide sedimentation coefficients that can provide insight into the oligomeric state of the
potential Wadjet complex. Distantly related condensin systems vary in their oligomeric
state based on ATP binding and ATP hydrolysis states; thus, these conditions would also
need to be assessed (Keenholtz et al., 2017).
Experiments that determine whether the A. vinelandii DJ Wadjet proteins inhibit
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plasmid transformation are needed, considering this particular set of Wadjet genes is only
composed of jetABC and no jetD. The absence of jetD in A. vinelandii DJ and many other
species poses an interesting question, as researchers found that jetD was required for
plasmid interference in Bacillus subtilils (Doron et al., 2018). Although it is tempting to
say that Wadjet systems in species without jetD may be inactive, it could be that these
species contain an endogenous protein that could perform the same function as jetD. This
may be an exciting story to follow where we could perform pull-down assays using
naturally expressed WADJET in the A. vinelandii DJ cell lines. This would require
learning homologous recombination techniques to add tags to endogenous jet genes in A.
vinelandii DJ.
A significant question to pursue would be how Wadjet systems can distinguish
between endogenous genomic material and foreign material such as a plasmid. It may be
that Wadjet can distinguish plasmid material through recognition of DNA supercoiling
state, the origin of replication recognition, or by being expressed when non-chromosomal
material such as plasmids are replicated. This hypothesis is based on the knowledge that
plasmids are self-replicating and can replicate independently of chromosomal DNA as
they have their own ORI sequence (Hayes, 2003). This then begs the question of whether
Wadjet is continuously expressed or whether specific cellular signals are needed to
induce the expression. This could be assessed by performing real-time PCR in A.
vinelandii DJ.
In conclusion, the work performed on Wadjet systems has resulted in the
successful cloning of A. vinelandii and M. MCS jet genes into expression vectors.
Furthermore, the first data showing AvJetB purifying as a dimer was presented. This data
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is significant as it supports the claim that Wadjet systems are similar to chromatin
condensin complexes.
In conclusion, the work presented in this thesis provides biochemical and
structural details on the enzyme CasDinG, which enhances the knowledge of both SF2
helicases and type IV-A CRISPR- Cas systems. The work on CasDinG fills a crucial gap
in the mechanism of type IV-A systems. Furthermore, work in this thesis revealed the
bioprocessing active site of SuCas12a2, laid a foundation for the study of Cas12a2
nucleases, and provided a foundation for the study of Wadjet plasmid inhibition systems.
Overall, this work has shown that basic research on novel prokaryotic immune systems
can result in the identification of potential DNA/RNA tools.
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APPENDIX A

Chapter 2 Supplementary Information
Supplementary Figures
Figure A-1
CasDinG Binding to Single-Stranded DNA of Variable Length (+ATP)
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Figure A-2
Mutant(s) CasDinG Binding to ssDNA (17 nt.)
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Figure A-3
Far UV-Circular Dichroism of CasDinG and Mutants
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Figure A-4
Oligonucleotides Used in CasDinG Assays

Note. Related to Table A-5
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Figure A-5
Binding of CasDinG to ssDNA (40 nt.) and Blunt DNA Duplex
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Figure A-6
Type IV-A RNP + CasDinG Binding to Target ssDNA TTTC PAM
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Figure A-7
Robetta Model of CasDinG with Mutations Marked
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Figure A-8
CasDinG Helicase Motifs Highlighted in the RecA Domains
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Figure A-9
EMBOSS-NEEDLE Alignment of PaCasDinG to E. coli DinG

########################################
# Program: needle
# Rundate: Thu 28 Jul 2022 19:33:16
# Commandline: needle
#
-auto
#
-stdout
#
-asequence emboss_needle-I20220728-193315-0439-45218992-p2m.asequence
#
-bsequence emboss_needle-I20220728-193315-0439-45218992-p2m.bsequence
#
-datafile EBLOSUM62
#
-gapopen 10.0
#
-gapextend 0.5
#
-endopen 10.0
#
-endextend 0.5
#
-aformat3 pair
#
-sprotein1
#
-sprotein2
# Align_format: pair
# Report_file: stdout
########################################
#=======================================
#
# Aligned_sequences: 2
# 1: CasDinG
# 2: E.coli
# Matrix: EBLOSUM62
# Gap_penalty: 10.0
# Extend_penalty: 0.5
#
# Length: 887
# Identity:
168/887 (18.9%)
# Similarity:
269/887 (30.3%)
# Gaps:
332/887 (37.4%)
# Score: 147.0
#
#
#=======================================
CasDinG

1 MKLAQGAFVDVIRIGALSPPTDQRSLWARTLLSEAVDQGLDSLPVPLQDV

50

E.coli

1 --------------------------------------------------

0

51 STFTVTLQPALAVRLKALADQHNTPVSVYAAGLIEAMRRRSESGSVAEAP
...|..|:..:|...|||.:|
1 MALTAALKAQIAAWYKALQEQ-----------------------------

100

101 MELPADALPGEGAVREVLRPLLKQAAEKTAA--GKIVFAEAATGTGK--G
:| |.:|
|...|.::...|:..|. |:.:..||.||.|| .
22 --IP-DFIP-----RAPQRQMIADVAKTLAGEEGRHLAIEAPTGVGKTLS

146

192

E.coli

147 RMIASLAAAAAIKGDTVVVSAPLAVTWQLVNDMKDIPEVRRV----GLTL
.:|..:|.|...:...||.:|.:|:..|:.: ||:|.::::
..|.
64 YLIPGIAIAREEQKTLVVSTANVALQDQIYS--KDLPLLKKIIPDLKFTA

111

CasDinG

193 SLGRPNFISPQR-TLEWAIDNERADLAAWIEGGGKPLSLRSMETSKVISH

241

CasDinG
E.coli
CasDinG
E.coli
CasDinG

21

63

148
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli
CasDinG
E.coli

:.||..::.|:. |...:.:..:.||.|:::....|.:....:....:..
112 AFGRGRYVCPRNLTALASTEPTQQDLLAFLDDELTPNNQEEQKRCAKLKG
242 ELCWLLEDALLLAEDLPADSLL--LTSEDPADCPAQQLY-------VAMR
:|.....|.|....|:..|..| ..|.|.|.|..:..|
...|
162 DLDTYKWDGLRDHTDIAIDDDLWRRLSTDKASCLNRNCYYYRECPFFVAR

161
282
211

283 SNYTEAGIILCSHFMLAAHTRMMQMRGLGNDEELDDEAPTGLSLPHFIDT
....||.:::.:|.::
|..:.::..|.| |..|
.
212 REIQEAEVVVANHALV--------MAAMESEAVLPD--PKNL-------L

332

333 LIVDEAHLLEQAFASVYTHTLRLRPLMRTIEGLGSRGRKPALDALK---|::||.|.|...
|.|||:
245 LVLDEGHHLPDV----------------------------ARDALEMSAE

378

379 ----------ELFTQMQVASARSTNTSLNVPLSDVP-----------ELI
:|||:: ||:.........:|...:|
|||
267 ITAPWYRLQLDLFTKL-VATCMEQFRPKTIPPLAIPERLNAHCEELYELI
408 PALKDTVK-------------TLGALPTKGMSRDARSVIRIATRAA--ND
.:|.:.:.
.:|.||.:
|:.|..|.| .:
316 ASLNNILNLYMPAGQEAEHRFAMGELPDE--------VLEICQRLAKLTE
443 ALSGHSRLRI----------EVTPVHSYPMLLSGRSNLQRALLGLWNATG
.|.|.:.|.:
::..:|...:.::....:..|...||....
358 MLRGLAELFLNDLSEKTGSHDIVRLHRLILQMNRALGMFEAQSKLWRLAS
483 GATLVSA--TLFTTGD--NGSLTRW------KLEVPTERAAFLPPVHPAW
.|....| |.:.|.: .|.|..|
::....||..:....|...
408 LAQSSGAPVTKWATREEREGQLHLWFHCVGIRVSDQLERLLWRSIPHIIV
523 TTAP------------------------VLLHKEF--CAH---------|:|.
|.|...| |..
458 TSATLRSLNSFSRLQEMSGLKEKAGDRFVALDSPFNHCEQGKIVIPRMRV

244

266
407
315
442
357
482
407
522
457
536
507

537 EP--DDSPEWATECAQTI-QGVASTAQGGTLVLCTSYQNTELLAGRLGAA
|| |:..:...|.|... :.|.|....|.|||..|
||....
508 EPSIDNEEQHIAEMAAFFRKQVESKKHLGMLVLFAS--------GRAMQR

583

584 LGD-----RLIVQSKTSSAATCLAQFKAKHKA-GIRPVWLGLGAAWTGID
..|
||::..:.......|.:...|..| |.|.|.:||.:...|:|
550 FLDYVTDLRLMLLVQGDQPRYRLVELHRKRVANGERSVLVGLQSFAEGLD

627

628 LSDHSLPD-------NPELDRLLSDLVITRIPVGQ-----NRSLTHERRT
|....|..
.|.:|
|.:|||.
|:
||.....:..
600 LKGDLLSQVHIHKIAFPPID---SPVVITE---GEWLKSLNRYPFEVQSL
666 AIGGFRIISQEAAWHFRQGLGRLVRRPGVTHKNLW----VLDARI----Y
....|.:|.|
:|||:|..|
.|
:.|.|:
|
644 PSASFNLIQQ---------VGRLIRSHG-----CWGEVVIYDKRLLTKNY
708 G----GAAWVAPFRQ------ILDRYKKA-------|
.|..|.|..|
|:.:.:|.
680 GKRLLDALPVFPIEQPEVPEGIVKKKEKTKSPRRRRR

#--------------------------------------#---------------------------------------

726
716

549

599
665
643
707
679
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Figure A-10
EMBOSS-NEEDLE alignment of PaCasDinG to S. aureus DinG
########################################
# Program: needle
# Rundate: Thu 28 Jul 2022 19:34:53
# Commandline: needle
#
-auto
#
-stdout
#
-asequence emboss_needle-I20220728-193533-0953-75622219-p1m.asequence
#
-bsequence emboss_needle-I20220728-193533-0953-75622219-p1m.bsequence
#
-datafile EBLOSUM62
#
-gapopen 10.0
#
-gapextend 0.5
#
-endopen 10.0
#
-endextend 0.5
#
-aformat3 pair
#
-sprotein1
#
-sprotein2
# Align_format: pair
# Report_file: stdout
########################################
#=======================================
#
# Aligned_sequences: 2
# 1: CasDinG
# 2: S.
# Matrix: EBLOSUM62
# Gap_penalty: 10.0
# Extend_penalty: 0.5
#
# Length: 1029
# Identity:
152/1029 (14.8%)
# Similarity:
292/1029 (28.4%)
# Gaps:
435/1029 (42.3%)
# Score: 110.0
#
#
#=======================================
CasDinG

1 --------------------------------------------------

0

S.

1 MGMATYAVVDLETTGNQLDFDDIIQIGITFVRNNQIIDTYHSMIRTNLEI

50

CasDinG

1 --------------------------------------------------

0

51 PPFIQALTSIEENMLQQAPYFNQVAQEIYDKIKDCIFVAHNVDFDLNFIK

100

1 -------MKLAQGAFVDVIRIGALSPPTDQRSLWARTLLSEAVDQGLDSL
::......:|.:.|..::.|||:
101 KAFKDCNIQYRPKKVIDTLEIFKIAFPTDK--------------------

43

S.
CasDinG
S.
CasDinG
S.
CasDinG

130

44 PVPLQDVSTFTVTLQPALAVRLKALADQHNTPVSVYAAGLIEAMRRRSES
:.:|..||:.|
|:..|...|::.
131 ------------------SYQLSELAEAH---------GITLANAHRADE

93
153

94 GSVAEAPM---------ELPADALPGEGAVREVL----------------

118

150
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.
CasDinG
S.

.:...|.:
:||.|.|.....:.:.|
154 DAATTAKLMILAFEKFEKLPLDTLKQLYYLSKQLKYDLYDIFFEMVRQYD

203

119 -RPLLK--QAAEKTAAGKIVFAEAATGTGKGRMIASLAAAAAIKGDTVVV
:||.| :..|:....|.|..:..| |.....:.||.:.|
204 AKPLDKSYEKFEQIIYRKQVDFKKPT-TNYNGSLKSLYSKA---------

165

166 SAPLAVTWQLVNDMKDIPEVRRVGLTLSLGRPNFISPQRT-LEWAIDNER
|.::|||.
||..:....| |:..:.:|:
244 -------------------VDQLGLTY---RPQQLYLAETILDQLMHSEK

214

215 ADLAAWIEGGGKPLS------LRSMETSKVISHELCWLLEDALLLAEDLP
|.:.|.: |.||.|:
:.::||.|.:.......|..:.||.:|:|
272 AMIEASL-GSGKSLAYLLAALMYNIETGKHVMISTNTKLLQSQLLEKDIP

243

271
258
320

259 A---------DSLLLTSEDPADCPAQQLYVAM----------RSNYTEAG
|
::||:.|:..
|:::
.||| |..
321 AMNEALNFKINALLIKSKSD--------YISLGLISQILKDDTSNY-EVN

289

290 IILCSHFMLAAHT-----RMMQMRG---LGNDEELDDEAPT--------|:.....:....|
:.:.::|
:..|::::...|.
362 ILKMQLLIWITETPSGDIQELNLKGGQKMYFDQKIETYVPARHDVHYYNF

322

323 ----------GL-------------SLPHFIDTLIVDEAHLLEQAFASVY
|:
|:....|..||||||.|.....:..
412 IKRNAQNIQIGITNHAHLIHSDVENSIYQLFDDCIVDEAHRLPDYALNQV
350 THTLRLRPLMRTIEGLGSRGRKPALDALKELFTQM---QVASARSTNTSL
|:.|....:...:..:|....:..|.|:.:|..|.
::..|......|
462 TNELSYADIKYQLGLIGKNENEKLLKAIDQLEKQRILEKLDIAPIDIFGL
397 NVPLSDVPELIPALKDTVKTL-----------------GALPTKGMSRDA
...::::.||...|..|:.|:
....||.:.:|.
512 KASMNEIHELNEQLFSTIFTIINDSDVYDDDIHRFHNVFTFETKDILKDL
430 RSVIRIATRAANDALSGHSRLRIEVTPVHSYPMLLSGR-SNLQRAL---.::|....:.. :..:|.|...:: .:....:.|..: .|::::|
562 HAIIDKLNKTL-EIFNGISHKTVK--SLRKQLLYLKDKFKNIEQSLKAGH
475 ---LGLWNATGGATL--------------------VSATLFTTGD---NG
:.:.|.:..:|:
..:.:|.:|.
|.
609 TSFISIKNLSQKSTIRLYVKDYAVKDVLTKQVLEKFKSLIFISGTLKFNH

361

411
349
461
396
511
429
561
474
608
498
658

499 SLTRWK-----------LEVPTERAAFLPPVHPAWTTAPVLLHKEFCAHE
|...:|
.||.|.
:..|..|: |.:..:..:::
659 SFEAFKQLFNKDVHFNTFEVNTS-------LQSAKNTS-VFIPSDVASYQ

537

538 PDDSPEWATECAQTIQGVASTAQGGTLVLCTSYQNTELLAGRLG--AALG
..:..|:.......|....:......|||.|||:...::...|. ....
701 YKNIDEYVASIVSYIIEYTTITSSKCLVLFTSYKMMHMVQDMLNELPEFE

585

586 DRLIVQSKTSSAATCLAQFKAKHKAGIRPVWLGLGAAWTGIDLSDHSLPD
|.:::..:.:.....:.||....||
:.||....:.|.|...:.
751 DYVVLTQQQNQNYKIVQQFNNFDKA----ILLGTSTFFEGFDFQANG---

635

636 NPELDRLLSDLVITRIPVGQNRS----LTHERRTAIGGFR-IISQEAAWH
:..::|.::|.....:
|.....|:. |: .:..:|...
794 -------IKCVMIAKLPFMNKHNAKYWLMDSEFTST--FKEYVLPDAVTR

680

681 FRQGLGRLVRRP---GV-----------THKNLWVLDARIYGGAAWVAPF
||||||||:|..
|:
.:||.
|
835 FRQGLGRLIRNENDRGIIVSFDDRLINSNYKNF----------------F

716

700

750

793

834

868
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CasDinG
S.

717 RQILDRYKKA------------------.|.|:.|::.
869 EQTLENYRQKKGDIQQFGKLLRQIQKKKK

726
897

#--------------------------------------#---------------------------------------

Supplementary Tables

Table A-1
Mutant(s) CasDinG Binding to ssDNA
Construct
ΔArch

Kd (nM)
42 +/- 4.9

ΔDEAH

94 +/- 18

ΔN. Terminus
Trunc.

65 +/- 9.6

Note. Related to Figure A-2.

Table A-2
CasDinG Binding to ssDNA and Blunt Duplex DNA
Substrate
ssDNA (17 nt.)
Blunt Duplex DNA

Kd (nM)
61 +/- 4.6
N/A

Table A-3
Constructs Generated of CasDinG by Hannah Domgaard
Construct
2RTPaDING Arch
K/O and
DEAH.AAAH

Antibiotic
AMP

Tag
N-strep

Notes
knocks out amino acids 418-537 of 2rtpading
and mutates DEAH_AAAH

152

2RTPaDING ED_AA
Set 2 324_325
2RTPaDING ED_AA
Set 1 317_318
2RTPaDING FeS
K/O Glycine Link
2RTPaDING N-Term
Truncation DEAHAAAH
2RTPaDING Arch
K/O
2RTPaDING N-Term
solo mutation
2RTPaDING N-Term
Short. Truncation
2RTPaDING Notag
(#2)
2RTPaDING NTERMINAL
TRUNCATION
DEAH_AAAH

Mutates ED_AA set in vFeS positions 324 and
325
Mutates ED_AA set1 in vFeS positions 317
and 318
knocks out amino acids 264-355, and adds in
a 5 glycine link

AMP

N-strep

AMP

N-strep

AMP

N-strep

AMP

N-strep

knocks out amino acids 1-195 of 2rtpading

AMP

N-strep

knocks out amino acids 418-537 of 2rtpading

AMP

N-strep

keeps only the N terminus 1-225 , known as
N terminus isolation

AMP

N-strep

knocks out amino acids 1-195 of 2rtpading

AMP

N-strep

same pet vector as 2rtpading but the strep
tag has been removed

AMP

N-strep

knocks out amino acids 1-195 of 2rtpading
and then mutates DEAH_AAAH

Table A-4
Substrates Used in CasDinG Assays
Oligo
Name
"DinG"

DNA
/RNA

14

DNA

17

DNA

20

DNA

21
36

DNA
RNA

Length
(nt).

Complementary
Partner

TCGTCACCAGTACAAAC

17

20,21,17,37

GTTTGTACTGGTGACGA
TTTTTTTTTTTTTTTTGTTT
GTACTGGTGACGA
GTTTGTACTGGTGACGAT
TTTTTTTTTTTTTTT
UCGUCACCAGUACAAAC

17

14

33

14

33
17

14
20

Sequence

Purpose
Helicase Assay,
Anisotropy Assay
Helicase Assay,
Anisotropy Assay
Helicase Assay,
Anisotropy Assay
Helicase Assay,
Anisotropy Assay
Helicase Assay

153

37

RNA

42

RNA

B2 (14
long)

DNA

UUUUUUUUUUUUUUUU
GUUUGUACUGGUGACGA 33
U*C*G*U*C*A*C*C*A*G
*U*A*C*A*A*A*C
17
TCGTCACCAGTACAAACTA
CAACGCCTGTAGCATTCCA
CA
40

36,14

43

Helicase Assay
Phosphorothioat
ed Anisotropy,
ATPase

19

Helicase , ATPase

Table A-5
Primers to Mutate and Sequence CasDinG
Name

PDinG_Ntrunc_F

Purpose
To PCR amplify the N
terminal domain of
PaDinG
To PCR amplify the N
terminal domain of
PaDinG
Mutates the Nterminal domain off
of PaDinG
Mutates the Nterminal domain off
of PaDinG
Mutates the Nterminal domain off
of PaDinG
Mutates the Nterminal domain off
of PaDinG
Mutates the Arch
domain off of PaDinG
Mutates the Arch
domain off of PaDinG
T7 forward primer
T7 terminal primer
Primer to truncate
Pa83 DinG by taking
off the N terminal
domain

PDinG_Ntrunc_R

Primer to truncate
Pa83 DinG by taking

N-Terminus Solo F

N-Terminus Solo R

N-Term KO Long F

N-Term KO Long R

N-TDm KO S F

N-TDm KO S R
Arch Dm KO F
Arch Dm KO R
HD_t7_F
HD_t7_term

Sequence

CGC GGC GAT TTA GGG CGA CAC A

GCG GCT GCC AGG GAA GCA
AAG GGC GAC ACA GTC GTT

CAA AGC TCC GAT CCT GAT TAC

ACT GCA GCA GGC AAG ATC

CAA AGC TCC GAT CCT GAT TAC

GGA CGA TCC AAC CTG CAG
GGT GTA GAC GGA CGC AAA
TAATACGACTCACTATAGGG
GCTAGTTATTGCTCAGCGG

TAACGGCCACCGGTACCGGCA
CCTCGGCAAAGACGATCTTGCCTGC

154
off the N terminal
domain

PADinG_DE258AA_F

PADinG_DE258AA_R

HD_FeSmotifKO_PaD
inG_glylink_F

HD_FeSmotifKO_glyli
nk_PaDinG_R

HD_NoTagPaDinG_F

HD_NoTagPaDinG_R

Mutagenesis primer
to change D258 to a
and E259 to A
Mutagenesis primer
to change D258 to a
and E259 to A
Mutagenesis primer
to knock out the FeS
domain using a 5
glycine linker
Mutagenesis primer
to knock out the FeS
domain using a 5
glycine linker
Mutagenesis primer
to take the tag off of
DinG
Mutagenesis primer
to take the tag off of
DinG

ATTGATCGTGGCGGCGGCGCACCTGC

GTGTCGATGAAGTGGGGG

GGTGGTGGTGGTCCTGCCCAGCAGCTGTAC

ACCACCACCACCCAGGCTTAGGGTAAGCCC

TCCCCACCGACAGACC

CATGCTAGCCATATGTATATCTCCTTCTTAAAG

Table A-6
Constructs of CasDinG Molecular Weights and Extinction Coefficients
Construct

Molecular Weight (Daltons) Extinction (M-1 cm-1)

Strep tag CasDinG ΔArch

68625.53

94420

Strep tag CasDinG ΔDEAH_AAAH

80915.93

95910

Strep tag CasDinG ΔN. Terminus Trunc.

69182.46

88920

Strep tag CasDinG ΔvFeS

72886.69

79410

Strep tag WT CasDinG

81131

95910

Type IV-A RNP

174612

463580

Type IV-A RNP + CasDinG

255743

559490
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Table A-7
ApoCasDinG Crystal Hits
ScreenCrystal type
Temperature/ (- shower, +
Well
needle)

Salt

[salt] M

Buffer

pH

[Buffer]
M

PEG

% PEG

Extra

% or [ ]

Drop:Protein

3350
MME
2000

20

0.3:0.2 uL

30

0.3:0.2 uL

3350

20

0.3:0.2 uL

3350

20

0.3:0.2 uL

MCSG II RT
A1-2

+

Na Tartrate

0.2

A2-2

-

K Br

0.15

A10-2

-

A11-2

B5-1

B11-2

++

NH4 Nitrate
pH6.3
Lithium
Chloride

-

NH4 Sulfate

-

Lithium
Sulfate

C4-2

-

c5-2

+

C9-2

-

D10-2

+

Sodium
Citrate
Sodium
Fluoride
Li Citrate
Tribasic

6.3

0.2

0.2

0.2

Na
Cacodylatte
pH 6.5

6.5

0.2

8000

30

0.3:0.3 uL

0.2

Bis-Tris:HCL
pH 6.5

6.5

0.1

3350

25

0.3:0.2 uL

NH4 Citrate
Tribasic

7

0.2

3350

20

0.3:0.2 uL

0.2

3350

20

0.3:0.2 uL

0.2

3350

20

0.3:0.2 uL

0.2

3350

20

0.3:0.2 uL

3350

20

0.3:0.1 uL

3350

20

0.3:0.2 uL

8000

30

0.3:0.1 uL

3350

20

0.3:0.2 uL

MCSG II 4C

A9-1
A11-2

-

Na Citrate:HCl
Lithium
Chloride

5

0.1

0.2

0.2

Na
Cacodylatte
pH 6.5

B5-1

-

B6-2

-

NH4 Sulfate
Sodium
Formate

6.5

0.2

C3-2

-

Ammonium
Acetate

0.2

HEPES:NaOH

7.5

0.1

3350

25

0.3:0.2 uL

B5-1

+

NH4
Sulfatte

0.2

Na
Cacodylatte
pH 6.5

6.5

0.2

8000

30

0.3:0.1 uL

E8-1

long skiny -

CHES:NaOH

9.5

0.1

8000

20

0.3:0.1 uL

3350

20

0.3:0.1 uL

0.3:0.3 uL

0.2

MCSG II 13 C

+

Sodium
Tartrate
Dibasic

0.2

A7-3

+

Calcium
Acetate

0.2

C5-3

-

Mg Acetate

F11-1
MCSG III 13C

8

0.1

8000

10

0.16

Imidazole
Na
Cacodylatte
pH 6.5

6.5

0.08

8000

16

0.2

Imidazole

8

0.1

8000

10

0.3:0.2 uL

0.2

8

0.1

8000

10

0.3:0.3 uL

6.5

0.08

8000

16

8.3

0.2

3350

20

glycerol

20

0.3:0.3 uL

MCSG III RT
A7-2

+

A7-3

+

Calcium
Acetate
Calcium
Acetate

C5-3

-

Mg Acetate

D10-2

++

Imidazole
Na
Cacodylatte
pH 6.5
K Citrate
Tribasic

E8-3

long skiny -

HEPES:NaOH

7.5

0.1

8000

10

F9

long skiny -

Imidazole

8

0.1

8000

10

++

K Citrate
Tribasic

8.3

0.2

3350

20

long skiny -

HEPES:NaOH

7.5

0.1

8000

10

0.16

glycerol

20

Ethylene
Glycol

10

Ethylene
Glycol

10

0.3:0.3 uL
0.3:0.2 uL
0.3:0.3 uL

MCSG III 4C
D10-2
E8-3

0.3:0.2 uL
0.3:0.3 uL
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Supplementary Methodology

Alphafold Model Molecular Replacement
An Alphafold generated model was utilized to solve the phases of the x-ray
diffraction data collected using the SSRL 9-2 beamline. First an Alphafold model was
generated using the Alphafold 2.0 google colab server. Next, the Alphafold model was
utilized in phaser (phenix program). The Alphafold model was trimmed of the arch
domain and n terminal domain and was ultimately composed of the helicase core domain
and the vestigial FeS domain (vFeS). Alphafold is able to generate a fairly reliable model
based off of MSA (multiple sequence alignments) however domain placement of models
may be biased if there is the presence of bound ligands such as nucleic acid or bound
metals. The trimmed Alphafold model resulted in a solve (TFZ score > 8) and resulted in
a low-resolution map. To improve the map, the Alphafold model was broken into
helicase core domain and vFeS domains and then a rigid body fit was performed on each
domain. Solvent flattening was then performed using the phenix program RESOLVE.
This allowed for sufficient improvement of phases such that CasDinG model could be fit
into the resulting electron density. The final model resulted in electron density for all
domains, excluding the N-terminus which was not resolved.
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APPENDIX B

Chapter 3 Supplementary Information
Supplementary Figures
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Figure B-1
SAXS-SEC of SuCas12a2

Note. SEC chromatogram at A280 of SuCas12a2 (also known as SuCms1). Shoulder
represents a larger species. B. SAXS SEC profile showing shoulder reversal confirming a
larger mass species. C. P(r) distribution shows negative values around r=30 indicative of
a micelle. D-max indicates something is embedded or inside the micelle. D. Log(q) plot
is that of a typical detergent, such as TWEEN 20. E. UV absorption for sample, another
indication of TWEEN 20.
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Figure B-2
I-TASSER Homology Model of SuCas12a2

Figure B-3
DALI Top 5 Server Results for AvJet Alphafold Models

Supplementary Tables
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Table B-1
Chapter 2 Construct Molecular Weights and Extinction Coefficients
Molecular Weight (Daltons) Extinction (M-1 cm-1)
143912.14
145890
161023.33
417590
128059.69
139930
145170.88
411630
17111.19
271700
38912.78
19940

Construct
SuCas12a2 Apo
SuCas12a2 RNP
C-terminal HIS SmCas12a2
HIS -SmCas12a2 RNP
Processed RNA guide
N term Sumo-HIS AvJetB

Table B-2
Substrates Used in Cas12a2 Assays
Name
SuRNA
80nt
TTTC_F_T
arget
TTTC_R_T
arget

Description
pre-crRNA used in
SuCas12a2
processing assay
DNA used in binding
and cleavage assay
DNA used in binding
cleavage assay

Sequence
GAACUUUAAAUAAUUGUCUAAACCGACCCAAUAAUUUCUAC
UGUUGUAGA UUGGAGCAACACCUGAAGGAAGGCUUGAUG
AACAACAAGAAGAACTCACCTTTCTGGAGCAACACCTGAAGGA
AGGCTTGATGAGCAAGTGCGGCAGCAAAGA
TCTTTGCTGCCGCACTTGCTCATCAAGCCTTCCTTCAGGTGTTGC
TCCAGAAAGGTGAGTTCTTCTTGTTGTT

Table B-3
Primers to Sequence and Mutate SuCas12a2 (Cms1)
Name

Description

Sequence

HDSunovel_licF

Primer to clone the novel domain out
of SuCms1 into LIC vectors

TACTTCCAATCCAATGCAAAACAGCT
TGCCACACTC

Primer to clone the novel domain out
HDSunovel_licR of SuCms1 into LIC vectors
HD_t7_F
T7 forward primer
HD_t7_term
T7 terminal primer
Primer to add a Strep Tag and Rhino
HDStrepRhino3 cleavage sequence to SuCms1 in the
182F
3182 construct
Primer to add a Strep Tag and Rhino
HDStrepRhino3 cleavage sequence to SuCms1 in the
182R
3182 construct

TTATCCACTTCCAATGTTATTAGTAAG
CCTTGTATGAATACTTAGC
TAATACGACTCACTATAGGG
GCTAGTTATTGCTCAGCGG
GGGTGCACTTGAAGTCCTCTTTCAGG
GACCCCTTCACGCTTTCACTAATC
TTTTCGAACTGCGGGTGGCTCCAGCT
TGCCATTGGTATATCTCCTTATTAAA
GTTAAAC
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HDStrRhi3182s
eq
2213_seq6
2213_seq5
2213_seq4
2213_seq3
2213_seq2
Sulf_Ruvc1_DA
_F
Sulf_Ruvc1_DA
_R
sulfRUVC2_ED_
AA_F
sulfRUVC2_ED_
AA_R
sulfRUVC3_DD
_AA_F
sulfRUVC3_DD
_AA_R
Sucms1_ruvc1s
eq_F
Sucms1_ruvc1s
eq_R
Sucms1_ruvc2s
eq_F
Sucms1_ruvc2s
eq_R
LIC_v1_suCMS
1_F
LIC_v1_suCMS
1_R
CMS1_2322_Ec
or1_F
CMS1_2322_K
pn1_R
RuvC3seqF

Primer used to sequence the Strep
Tag and Rhino sequence of the 3182
construct
primer to sequence 2213 construct
Apo SuCms1
primer to sequence 2213 construct
Apo SuCms1
primer to sequence 2213 construct
Apo SuCms1
primer to sequence 2213 construct
Apo SuCms1
primer to sequence 2213 construct
Apo SuCms1
primer to mutate SuCms1 ruvC1
aspartate to alanine
primer to mutate SuCms1 ruvC1
aspartate to alanine
primer to mutate SuCms1 ruvC2
aspartate/glutamate to alanines
primer to mutate SuCms1 ruvC2
aspartate/glutamate to alanines
primer to mutate Sucms1 ruvC3
glutamates to alanines
primer to mutate Sucms1 ruvC3
glutamates to alanines
Primer to sequence SuCms1 ruvc1
domain
Primer to sequence SuCms1 ruvc1
domain
Primer to sequence SuCms1 ruvc2
domain
Primer to sequence SuCms1 ruvc2
domain
Primer to clone SuCms1 into LIC
vectors
Primer to clone SuCms1 into LIC
vectors
Primer to add EcoR1 site to N
terminus of SuCms1
Primer to add Kpn1 site to C terminus
of SuCms1
Primer to sequence SuCms1 RuvC3
domain

CTGATAAGAGACACCGGC
GGAGAAAATCTACTACAGGAC
GCAATAGCCACTAACGGTG
CTGCTTTATATCAGGAAGAATC
GAGCCTTACAAGCAAAACATTG
CTTTAACGATGAAGACGTTCAG
TTGAGGCCTCTAGCAATACCAATAAC
ACAGCTTGCCACACTCTG
CTCTTGACAAAGCCGCAAGAGAGAT
G
CCTATGGAGGTGCAAAGTC
ATGCACCGTTAGCGGCCCCGTTGTGA
ACCACATCGCCCTTAAGAGCGTTG
GCACTTTCCGACAAAGAATACG
CTGCTTGTGTGTGTTCCCAA
AGATGCTGCAGACAACCTTAA
GTACCCAAACCTGCAAGCAT
TACTTCCAATCCAATGCAAATATAAT
GAATGTTATTCTCTCTT
TTATCCACTTCCAATGTTATTAAGAG
CCTATGGAGGTGC
AATTCAACAACAAGAAGAACACCTTT
CTG
CCTTTGCTGCCGCACTTGC
TCGGCGTTGTTCATTTCATA
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HDStRhi3182n
oCR_F

Primer used to eliminate the CRISPR
from the strep-rhino 3182 construct

TAAACCGACCCAAGGTAC

HDStRhi3182n
oCR_R

Primer used to eliminate the CRISPR
from the strep-rhino 3182 construct

CCCTATAGTGAGTCGTATTAG

Table B-4
Primers to Sequence and Mutate SmCas12a2 (Cms1)
Name

C_S_mut_234&243_F

C_S_mut_234&243_R

C_S_mut_291&297_F

C_S_mut_291&297_R
C_S_mut_303_F
C_S_mut_303_R

C_A_mut_234&243_F

C_A_mut_234&243_R

C_A_mut_291&297_F

C_A_mut_291&297_R
C_A_mut_303_F

Description
Cysteine to Serine mutant
for SmCms1 position 234
and 243
Cysteine to Serine mutant
for SmCms1 position 234
and 243
Cysteine to Serine mutant
for SmCms1 position 291
and 297
Cysteine to Serine mutant
for SmCms1 position 291
and 297
Cysteine to Serine mutant
for SmCms1 position 303
Cysteine to Serine mutant
for SmCms1 position 303
Cysteine to Alanine mutant
for SmCms1 position 234
and 243
Cysteine to Alanine mutant
for SmCms1 position 234
and 243
Cysteine to Alanine mutant
for SmCms1 position 291
and 297
Cysteine to Alanine mutant
for SmCms1 position 291
and 297
Cysteine to Alanine mutant
for SmCms1 position 303

Sequence

CGGGCTGTGCGTCGTTTCAAAGACTATG

AAGAGCCTGGTGGTGCTGGTTTCTTC

TGCTGAATGCGGCTTTGACACCC
AAAGCCGAAACCTTCCTGCTTGTTTTTAT
C
CAAATGCCAACGCTTTGGCTTTGACAC
CAGAAACCTTCCTGCTTG

TCGGGGCCTGCGTCGTTTCAAAGAC

AGGCCCTGGTGGTGCTGGTTTCTTC

TTGGCCAATGCGGCTTTGACACC
AGCCCAGAAACCTTCCTGCTTGTTTTTAT
C
CAAATGCCAACCGGCGGCTTTGACAC
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C_A_mut_303_R

Ruvc1_ncms1_seq_L

Ruvc1_ncms1_seq_R
NCMS1_CPKC_L_sq
NCMS1_CPKC_R_sq

Smcms1Ruv1_D_A_F

Smcms1Ruv1_D_A_R

Cysteine to Alanine mutant
for SmCms1 position 303
primer to sequence the
first ruvc domain in
smCms1
primer to sequence the
first ruvc domain in
smCms1
primer to sequence CPKC
mutant
primer to sequence CPKC
mutant
Primer to mutate SmCms1
RuvC1 domain from an
aspartate to alanine
Primer to mutate SmCms1
RuvC1 domain from an
aspartate to alanine

primer to mutate SmCms1
RuvC2 domain from
glutamate/aspartate to
Smcms1Ruv2ED_AA_F alanines

Smcms1Ruv2ED_AA_
R
Smcms1Ruv3_D_A_F
Smcms1Ruv3_D_A_R
SmRuvC1seq121318
SmRuvC2seq121318
SmRuvC3seq121318

Cms1_RuvC3_D_A_F

Cms1_RuvC3_D_A_R

primer to mutate SmCms1
RuvC2 domain from
glutamate/aspartate to
alanines
Primer to mutate smcms1
ruvc3 aspartate to alanine
Primer to mutate smcms1
ruvc3 aspartate to alanine
SmCms1 RuvC1 sequencing
primer
Smcms1 RuvC2 sequencing
primer
SmCms1RuvC3 sequencing
primer
Mutates the RuvC3 domain
from an aspartate to
alanine. SmCms1
Mutates the RuvC3 domain
from an aspartate to
alanine. SmCms1

CAGAAACCTTCCTGCTTG

TGAACCGGAGAAACGTAACC

TCGTTCAGAAAATAGCTCAGGT
CTGGAATGGGCGCTGTATC
TCCGTTATCCACTTCCAATGT

TATGGTATCGCCGCGGGCGAA

AAACCACAGTTGGTTCTTGTTGAAC

ATTAGCATCGCAGCCCTGAAACAAAC

GATGCCACGATATTTCTG
AACGACCCGGCCAAGGTGGCG
CAGGCCCTCAAAACCCTTCAG
GGTTTTTCACGGATAACCAGCTC
CTCCAGTTCACGCAGCTTAATC
CTTCCTTTCGGGCTTTGTTAG

AACGACCCGGCCAAGGTGGCG

CAGGCCCTCAAAACCCTTCAG
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Cms1_RuvC1_D_A_F

Cms1_RuvC1_D_A_R

Cms1_RuvC2_E_A_F

Cms1_RuvC2_E_A_R
smcms1_ruvc1_seqF
smcms1_ruvc1_seqR

Mutates the RuvC1 domain
from an aspartate to
alanine. SmCms1
Mutates the RuvC1 domain
from an aspartate to
alanine. SmCms1
Mutates the RuvC2 domain
from a glutamate to
alanine. SmCms1
Mutates the RuvC2 domain
from a glutamate to
alanine. SmCms1
Primer for sequencing
RuvC1 domain of Smcms1
Primer for sequencing
RuvC1 domain of Smcms1

TATGGTATCGCCGCGGGCGAA

AAACCACAGTTGGTTCTTGTTGAAC

ATTAGCATCGCAGACCTGAAAC

GATGCCACGATATTTCTG
AACGAAATTACCTTCGCGTTTG
GTATACTGTTCGTGCAGGTAACG

Table B-5
Primers to Clone and Sequencing Wadjet
Name
HD_MMJetA_seq
1
HD_MMJetA_seq
2
HD_MMJetC_Seq
1
HD_MMJetC_Seq
2
HD_MMJetCseq3
HD_AV_JetA_seq
1
HD_AV_JetA_seq
2
HD_AV_JetC_seq
1
HD_AV_JetC_seq
2
HD_AV_JetC_seq
3

Description
Primer used to sequence jetA from
Mycobacterium MCS
Primer used to sequence jetA from
Mycobacterium MCS
Primer used to sequence jetC from
Mycobacterium MCS
Primer used to sequence jetC from
Mycobacterium MCS
Primer used to sequence jetA from
Mycobacterium MCS
Primer used to sequence jetA from
Azotobacter vinelandii
Primer used to sequence jetA from
Azotobacter vinelandii
Primer used to sequence jetC from
Azotobacter vinelandii
Primer used to sequence jetC from
Azotobacter vinelandii
Primer used to sequence jetC from
Azotobacter vinelandii

Sequence
AGTCGCCGATCTTGAAACTC
AGCAGATGTTCTGGTCGC
ACCCGTTCGATCTGCTCG
ACGACATCGACGGCCTCG
AACTCGCGGACGAACTGTTC
CAATCGATGTCCTTGAGTGTC
AACGCTCACGCATAGCTC
ATGCATCGCCTTGATGCG
AGCTGAGCAACTGGGTGAC
AAGCGTTCTTTGCCCGAC
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HD_AV_JetC_seq
4
HD_MMJetA_seq
3
HD_avJETA_F
HD_avJETA_R
HD_avJETB_F
HD_avJETB_R
HD_avJETC_F
HD_avJETC_R
HD_mmJETA_F
HD_mmJETA_R
HD_mmJETB_F
HD_mmJETB_R
HD_mmJETC_F
HD_mmJETC_R

Primer used to sequence jetc from
Azotobacter vinelandii
Primer used to sequence jetA from
Mycobacterium MCS
Primer to clone the jetA gene from
Azotobacter vinelandii DJ
Primer to clone the jetA gene from
Azotobacter vinelandii DJ
Primer to clone the jetB gene from
Azotobacter vinelandii DJ
Primer to clone the jetB gene from
Azotobacter vinelandii DJ
Primer to clone the jetC gene from
Azotobacter vinelandii DJ
Primer to clone the jetC gene from
Azotobacter vinelandii DJ
Primer to clone the jetA gene from
Mycobacterium MCS
Primer to clone the jetA gene from
Mycobacterium MCS
Primer to clone the jetB gene from
Mycobacterium MCS
Primer to clone the jetB gene from
Mycobacterium MCS
Primer to clone the jetC gene from
Mycobacterium MCS
Primer to clone the jetC gene from
Mycobacterium MCS

AGAGCCTGTTTATCCTGCAAC
AGACCCCTGAAGATTTGGAC
TACTTCCAATCCAATGCAATGGA
GGATGCGCTAC
TTATCCACTTCCAATGTTATTATC
ACAACTCCCAATCGATG
TACTTCCAATCCAATGCAATGGA
TGATGAACAAACTGTC
TTATCCACTTCCAATGTTATTATC
ATGCCATATCCTCCTC
TACTTCCAATCCAATGCAATGGG
CGCTGTGCTCTG
TTATCCACTTCCAATGTTATTATC
AGTGGGCGACTTCATGCATC
TACTTCCAATCCAATGCAATGCA
GGTGGACGACAAC
TTATCCACTTCCAATGTTATTATC
ACTGCGAAACTCCAGC
TACTTCCAATCCAATGCAATGAC
CTCTCCGTCCAC
TTATCCACTTCCAATGTTATTATC
AGTCAACGTGGACCTC
TACTTCCAATCCAATGCAATGAC
TGAACAGTTTCACCTGTCGCG
TTATCCACTTCCAATGTTATTATC
AGACCCCGGCGGG

Table B-6
Chapter 2 Constructs Cloned By Hannah Domgaard
Construct
2ST_AVJetA
2ST_AVJetB
2ST_MMJetA
2ST_MMJetC
2RT_AVJetA
2RT_AVJetC
2RT_MMJetB
2RT_MMJetC
2ST_SuCas12a2_NovelDomain
SuCas12a2_∆3182_strep_rhino

Antibiotic
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
AMP
CAM

Tag
N-Sumo-HIS
N-Sumo-HIS
N-Sumo-HIS
N-Sumo-HIS
N-strep
N-strep
N-strep
N-strep
N-Sumo-HIS
N Strep Rhino

Notes
Azotobacter Vinelandii
Azotobacter Vinelandii
Mycobacterium MCS
Mycobacterium MCS
Azotobacter Vinelandii
Azotobacter Vinelandii
Mycobacterium MCS
Mycobacterium MCS
Sulfuricurvum Novel Domain
Sulfuricurvum 3182 construct
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2BT_SmCas12a2 ∆RuvC1+2
SuCas12a2_∆RuvC3
N-SmCas12a2_C->A_group1
N-SmCas12a2 ∆RuvC2
N-SmCas12a2 ∆RuvC3
SuCas12a2 ∆RuvC2 +3

AMP
CAM
AMP
AMP
AMP
AMP

N HIS
N HIS
N HIS
N HIS
N HIS
N HIS

Smithella
Sulfuricurvum
Smithella zinc finger mutant
Smithella
Smithella
Sulfuricurvum

